Advertisement

Strumenti diagnostici

  • Timothy B. Hargreave
  • Frank Comhaire
  • Ahmed Mahmoud
  • Hans Gerd Schiefer
  • Alexander von Graevenitz
  • Dietrich Klingmüller
  • N. Bliesener
  • Gerhard Haidl
  • Marc E. Bracke
  • Els L. F. Nijs
  • Raymond H. Oyen
  • Yigal Gat
  • Michael Gornish
  • Martin Bergmann
  • David J. Elliott
  • Oleg Tatarov
  • David Kirk

Riassunto

Un vecchio adagio medico dice che i migliori strumenti diagnostici sono un’accurata anamnesi e un esame obiettivo minuzioso, e che l’uso più appropriato dell’imaging e degli esami di laboratorio selettivi serve a conferma della diagnosi clinica. Un altro metodo consiste nel prescrivere un gran numero di test ematici di screening, di MRI total-body, ecc., ma un simile approccio può portare a falsi risultati, i quali, a loro volta, potranno condurre a indagini costose, talvolta sgradevoli e potenzialmente a rischio per il paziente e che possono non essere necessarie. Tuttavia, a causa delle sempre più raffinate conoscenze nell’ambito della medicina molecolare, i test ematochimici giocheranno probabilmente un ruolo maggiore sia per la diagnosi che per lo screening, utilizzando nuove tecniche molecolari come lo screening dei geni e delle proteine, in particolare in alcuni gruppi a rischio. In questo capitolo viene messo l’accento sull’anamnesi e sull’esame clinico classici per i problemi andrologici più comuni.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Chandley AC, Hargreave TB, Fletcher JM, Soos JM, Axworthy D, Price WH (1980) Trisomy 8. Report of a mosaic human male with nearnormal phenotype and normal IQ, ascertained through infertility. Hum Genet 55:31–38PubMedGoogle Scholar
  2. Hargreave TB (1990) Questionnaire for the infertile couple. In: Hargreave TB, Soon E (eds) Management of male infertility. PG Press, Singapore, p3Google Scholar
  3. Lewis EL, Rasor MO, Overstreet JW (1985) Measurement of human testicular consistency by tonometry. Fertil Steril 43:911–916PubMedGoogle Scholar
  4. Riley SA, Lecarpentier J, Mani V, Goodman Mi, Mandal BK Turnberg LA (1987) Sulphasalazine-induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution. Gut 28:1008–1012PubMedGoogle Scholar
  5. Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AMA (2000) WHO manual for the standardized investigation, diagnosis and management of the infertile male. Cambridge University Press, CambridgeGoogle Scholar
  6. Takihara H, Sakatoku J, Fujii M, Nasu T, Cosentino IM, Cockett ATK (1983) Significance of testicular size measurement in andrology. I. A new orchiometer and its clinical application. Fertil Steril 39:836–840PubMedGoogle Scholar
  7. Thorner MO, McNeilly AS, Hagan C, Besser GM (1974) Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. Br Med J ii:419Google Scholar
  8. WHO (1987) Towards more objectivity in diagnosis and management of male infertility. Int J Androl (Suppl 7)Google Scholar
  9. Yaukey D (1961) Fertility differences in a modernising country: a survey of Lebanese couples. Princeton University Press, Princeton, N.J.Google Scholar

Bibliografia

  1. Aiman J, McAsey M, Harms L (1988) Serum and seminal plasma prolactin concentrations in men with normospermia, oligospermia, or azoospermia. Fertil Steril 49:133–137PubMedGoogle Scholar
  2. Aitken RJ, Clarkson JS (1987) Cellular basis of defective sperm function and its association with the genesis of reactive oxygen species by human spermatozoa. J Reprod ertil 81:459–469Google Scholar
  3. Andreou E, Mahmoud A, Vermeulen L, Schoonjans F, Comhaire F (1995) Comparison of different methods for the investigation of antisperm antibodies on spermatozoa, in seminal plasma and in serum. Hum Reprod 10:125–131PubMedGoogle Scholar
  4. Bain J, Duthie M, Keene J (1979) Relationship of seminal plasma testosterone and dihydrotestosterone to sperm count and motility in man. Arch Androl 2:35–39PubMedGoogle Scholar
  5. Barros C, Gonzelez J, Herrera E, Bustos-Obregon E (1978) Fertilizing capacity of human spermatozoa evaluated by actual penetration of foreign eggs. Contraception 17:87–92PubMedGoogle Scholar
  6. Comhaire FH, Bosmans E (1993) Cytokines in semen of normal men and of patients with andrological diseases. The American Fertility Society conjointly with the Canadian Fertility and Andrology Society, 11–14 October 1993, Montreal, Quebec, Canada. Fertil Steril Program Supplement:S44–S45Google Scholar
  7. Comhaire F, Verschraegen G, Vermeulen L (1980) Diagnosis of accessory gland infection and its possible role in male infertility. Int J Androl 3:32–45PubMedGoogle Scholar
  8. Comhaire F, Vermeulen L, Ghedira K, Mas J, Irvine S, Callipolitis G (1983) Adenosine triphosphate in human semen: a quantitative estimate of fertilizing potential. Fertil Steril 40:500–504PubMedGoogle Scholar
  9. Comhaire FH, Vermeulen L, Pieters O (1989) Study of the accuracy of physical and biochemical markers in semen to detect infectious dysfunction of the accessory sex glands. J Androl 10:50–53PubMedGoogle Scholar
  10. Comhaire FH, Vermeulen L, Fagla B (1990) Tests of spermatozoa function: ATP. In: Acosta AA, Swanson RJ, Ackerman SB, Kruger TF, van Zyl JA, Menkveld R (eds) Human spermatozoa in assisted reproduction. Williams and Wilkins, Baltimore, pp 102–105Google Scholar
  11. Comhaire FH, Huysse S, Hinting A, Vermeulen L, Schoonjans F (1992) Objective semen analysis: has the target been reached? Hum Reprod 7:237–241PubMedGoogle Scholar
  12. Comhaire F, Bosmans E, Ombelet W, Punjabi U, Schoonjans F (1994a) Cytokines in semen of normal men and of patients with andrological diseases. Am J Reprod Immunol 31:99–103PubMedGoogle Scholar
  13. Comhaire F, Schoonjans F, Vermeulen L, De Clercq N (1994b) Methodological aspects of sperm morphology evaluation: comparison between strict and liberal criteria. Fertil Steril 62:857–861PubMedGoogle Scholar
  14. Comhaire FH, Christophe AB, Zalata AA, Dhooge WS, Mahmoud AM, Depuydt CE (2000) The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. Prostaglandins Leukot Essent Fatty Acids 63:159–165PubMedGoogle Scholar
  15. Comhaire F, Mahmoud A, Schoonjans [ F, Kint J (2002) Why do we continue to determine α-glucosidase in human semen? Andrologia 34:8–10PubMedGoogle Scholar
  16. Davis RO, Niswander PW, Katz DF (1992) New measures of sperm motion. I. Adaptive smoothing and harmonic analysis. J Androl 13:139–152PubMedGoogle Scholar
  17. Delanghe J, Comhaire F, de Buyzere M, Vermeulen L (1985) Altered glycosylation of gamma-glutamyltranspeptidase (GGT) in seminal fluid from men with accessory gland infection. Int J Androl 8:186–192PubMedGoogle Scholar
  18. Eliasson R (1971) Standards for investigation of human semen. Andrologie 3:49–64Google Scholar
  19. Eliasson R, Virji N (1985) LDH-C4 in human seminal plasma and its relationship to testicular function. II. Clinical aspects. Int J Androl 8:201–214PubMedGoogle Scholar
  20. Endtz AW (1972) Een methode om het vochtige urine sediment en het vochtige menselijk sperma rechtstreeks te kleuren. Ned Tijdschr Geneeskd 116:681–685PubMedGoogle Scholar
  21. Fiorelli G, Orlando C, Caldini AL, Cuomo S, Serio M (1982) ATP and ADP measurement in human spermatozoa by luciferin-luciferase system. In: Serio M, Pazzagli M (eds) Luminescent assays: perspective in endocrinology and clinical chemistry. Raven, New York, pp 79–87Google Scholar
  22. Garem YFE, Arini AFE, Beheiry AHE, Zeid SAA, Comhaire FH (2002) Possible relationship between seminal plasma inhibin B and spermatogenesis in patients with azoospermia. J Androl 23:825–829PubMedGoogle Scholar
  23. Gerozissis K, Jouannet P, Soufir JC, Dray F (1982) Origin of prostaglandins in human semen. J Reprod Fertil 65:401–404PubMedGoogle Scholar
  24. Ginsburg KA, Moghissi KS, Abel EL (1988) Computer-assisted human semen analysis. Sampling errors and reproducibility. J Androl 9:82–90PubMedGoogle Scholar
  25. Gonzales GF, Garcia-Hjarles M, Napuri R (1988) Corrected seminal fructose levels: index of secretory activity of seminal vesicles. Arch Androl 21:135–142PubMedGoogle Scholar
  26. Halsted JA, Smith JC Jr., Irwin MI (1974) A conspectus of research on zinc requirements of man. J Nutr 104:345–378PubMedGoogle Scholar
  27. Hellinga G (1949) Het onderzoek bij stoornissen in de mannelijke vruchtbaarheid (The investigation in case of male subfertility). Academic Thesis, AmsterdamGoogle Scholar
  28. Hellinga G (1976) Clinical andrology. William Heinmann, LondonGoogle Scholar
  29. Hellinga G, Ruward R, Oppers VM (1973) The influence of fixation and staining on the morphology of spermatozoa. In: Fertility and sterility. Proceedings of the VII World Congress, Japan, Exerpta Medica, Amsterdam, pp 233–235Google Scholar
  30. Henkel R, Müller C, Miska W, Gips H, Schill WB (1993) Determination of the acrosome reaction in human spermatozoa is predictive of fertilization in vitro. Hum Reprod 8:2128–2132PubMedGoogle Scholar
  31. Henkel R, Müller C, Miska W, Schill WB, Kleinstein J, Gips H (1995) Acrosin activity of human spermatozoa by means of a simple gelatinolytic technique: a method useful for IVF. J Androl 16:272–277PubMedGoogle Scholar
  32. Henkel R, Kierspel E, Hajimohammad M, Stalf T, Hoogendijk C, Mehnert C, Menkveld R, Schill WB, Kruger TF (2003) DNA fragmentation of spermatozoa and assisted reproduction technology. Reprod Biomed Online 7:477–484PubMedGoogle Scholar
  33. Henkel R, Hajimohammad M, Stalf T, Hoogendijk C, Mehnert C, Menkveld R, Gips H, Schill WB, Kruger TF (2004) Influence of deoxyribonucleic acid damage on fertilization and pregnancy. Fertil Steril 81:965–972PubMedGoogle Scholar
  34. Hinting A, Comhaire F, Schoonjans F (1988a) Capacity of objectively assessed sperm motility characteristics in differentiating between semen of fertile and subfertile men. Fertil Steril 50:635–639PubMedGoogle Scholar
  35. Hinting A, Schoonjans F, Comhaire F (1988b) Validation of a singlestep procedure for the objective assessment of sperm motility characteristics. Int J Androl 11:277–287PubMedGoogle Scholar
  36. Holt WV, Moore HD, Hillier SG (1985) Computer-assisted measurement of sperm swimming speed in human semen: correlation of results with in vitro fertilization assays. Fertil Steril 44:112–119PubMedGoogle Scholar
  37. Huszar G, Corrales M, Vigue L (1988) Correlation between sperm creatine phosphokinase activity and sperm concentrations in normospermic and oligospermic men. Gamete Res 19:67–75PubMedGoogle Scholar
  38. Huszar G, Vigue L, Corrales M (1990) Sperm creatine kinase activity in fertile and infertile oligospermic men. J Androl 11:40–46PubMedGoogle Scholar
  39. Irvine DS, Aitken RJ (1985) The value of adenosine triphosphate (ATP) measurements in assessing the fertilizing ability of human spermatozoa. Fertil Steril 44:806–813PubMedGoogle Scholar
  40. Jeyendran RS, van der Ven HH, Kennedy WP, Heath E, Perez-Pelaez M, Sobrero AJ, Zaneveld LJ (1985) Acrosomeless sperm. A cause of primary male infertility. Andrologia 17:31–36PubMedGoogle Scholar
  41. Katz DF, Davis RO (1987) Automatic analysis of human sperm motion. J Androl 8:170–181PubMedGoogle Scholar
  42. Katz DF, Davis RO, Delandmeter BA, Overstreet JW (1985) Realtime analysis of sperm motion using automatic video image digitization. Comput Methods Programs Biomed 21:173–182PubMedGoogle Scholar
  43. Katz DF, Overstreet JW, Samuels SJ, Niswander PW, Bloom TD, Lewis EL (1986) Morphometric analysis of spermatozoa in the assessment of human male fertility. J Androl 7:203–210PubMedGoogle Scholar
  44. Kremer J (1965) A simple sperm penetration test. Int J Fertil 10:209–215PubMedGoogle Scholar
  45. Kremer J, Jager S (1992) The significance of antisperm antibodies for sperm-cervical mucus interaction. Hum Reprod 7:781–784PubMedGoogle Scholar
  46. Kroeks MV, Kremer J (1975) The fractional post-coital test performed in a square capillary tube. Acta Eur Fertil 6:371–375PubMedGoogle Scholar
  47. Kruger TF, Oehninger S, Franken DR, Hodgen GD (1991) Hemizona assay: use of fresh versus salt-stored human oocytes to evaluate sperm binding potential to the zona pellucida. J In Vitro Fert Embryo Transf 8:154–156PubMedGoogle Scholar
  48. Lenzi A, Culasso F, Gandini L, Lombardo F, Dondero F (1993) Placebocontrolled, double-blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod 8:1657–1662PubMedGoogle Scholar
  49. Liu DY, Cooper EJ, Baker HW (1986) Seminal transferrin, an index of Sertoli cell function: is it of clinical value? Clin Reprod Fertil 4:191–197PubMedGoogle Scholar
  50. MacLeod IC, Irvine DS, Masterton A, Taylor A, Templeton AA (1994) Assessment of the conventional criteria of semen quality by computer-assisted image analysis: evaluation of the Hamilton-Thorn motility analyser in the context of a service andrology laboratory. Hum Reprod 9:310–319PubMedGoogle Scholar
  51. MacLeod J (1942) An analysis in human semen of a staining method for differentiating live and dead spermatozoa. Anat Rec 83:573–578Google Scholar
  52. MacLeod J, Gold RZ (1951) The male factor in fertility and infertility. IV. Sperm morphology in fertile and infertile marriage. Fertil Steril 2:394–414PubMedGoogle Scholar
  53. MacLeod J, Gold RZ (1953) The male factor in fertility and infertility. VI. Semen quality and certain other factors in relation to ease of conception. Fertil Steril 4:10–33PubMedGoogle Scholar
  54. Mahmoud AM, Comhaire FH, Vermeulen L, Andreou E (1994) Comparison of the resazurin test, adenosine triphosphate in semen, and various sperm parameters. Hum Reprod 9:1688–1693PubMedGoogle Scholar
  55. Mahmoud AM, Depoorter B, Piens N, Comhaire FH (1997) The performance of 10 different methods for the estimation of sperm concentration. Fertil Steril 68:340–345PubMedGoogle Scholar
  56. Mahmoud AM, Geslevich J, Kint J, Depuydt C, Huysse L, Zalata A, Comhaire FH (1998) Seminal plasma alpha-glucosidase activity and male infertility. Hum Reprod 13:591–595PubMedGoogle Scholar
  57. Makler A (1978) A new multiple exposure photography method for objective human spermatozoal motility determination. Fertil Steril 30:192–199PubMedGoogle Scholar
  58. Mann T, Mann CL (eds) (1981) Male reproductive function and semen. Springer, Berlin Heidelberg New York, pp 171–174Google Scholar
  59. Marmar JL, Katz S, Praiss DE, DeBenedictis TJ (1975) Semen zinc levels in infertile and postvasectomy patients and patients with prostatitis. Fertil Steril 26:1057–1063PubMedGoogle Scholar
  60. Mather JP, Gunsalus GL, Musto NA, Cheng CY, Parvinen M, Wright W, Perez-Infante V, Margioris A, Liotta A, Becker R, Krieger DT, Bardin CW (1983) The hormonal and cellular control of Sertoli cell secretion. J Steroid Biochem 19:41–51PubMedGoogle Scholar
  61. Menkveld R, Stander FS, Kotze TJ, Kruger TF, van Zyl JA (1990) The evaluation of morphological characteristics of human spermatozoa according to stricter criteria. Hum Reprod 5:586–592PubMedGoogle Scholar
  62. Miska W, Mahmoud M (1993) Determination of soluble interleukin-2 receptor in human seminal plasma. Arch Androl 30:23–28PubMedGoogle Scholar
  63. Mobley DF (1975) Semen cultures in the diagnosis of bacterial prostatitis. J Urol 114:83–85PubMedGoogle Scholar
  64. Montamat EE, Blanco A (1976) Subcellular distribution of the lactate dehydrogenase isozyme specific for testis and sperm. Exp Cell Res 103:241–245PubMedGoogle Scholar
  65. Nahoum CR, Cardozo D (1980) Staining for volumetric count of leukocytes in semen and prostate-vesicular fluid. Fertil Steril 34:68–69PubMedGoogle Scholar
  66. Oehninger S, Franken D, Alexander N, Hodgen GD (1992) Hemizona assay and its impact on the identification and treatment of human sperm dysfunctions. Andrologia 24:307–321PubMedGoogle Scholar
  67. Okamura N, Tajima Y, Ishikawa H, Yoshii S, Koiso K, Sugita Y (1986) Lowered levels of bicarbonate in seminal plasma cause the poor sperm motility in human infertile patients. Fertil Steril 45:265–272PubMedGoogle Scholar
  68. Orlando C, Caldini AL, Barni T, Wood WG, Strasburger CJ, Natali A, Maver A, Forti G, Serio M (1985) Ceruloplasmin and transferrin in human seminal plasma: are they an index of seminiferous tubular function? Fertil Steril 43:290–294PubMedGoogle Scholar
  69. Overstreet JW, Katz DF, Hanson FW, Fonseca JR (1979) A simple inexpensive method for objective assessment of human sperm movement characteristics. Fertil Steril 31:162–172PubMedGoogle Scholar
  70. Page EW, Houlding F (1951) The clinical interpretation of 1000 semen analyses among applicants for sterility studies. Fertil Steril 2:140–151PubMedGoogle Scholar
  71. Parvinen M, Soder O, Mali P, Froysa B, Ritzen EM (1991) In vitro stimulation of stage-specific deoxyribonucleic acid synthesis in rat seminiferous tubule segments by interleukin-1 alpha. Endocrinology 129:1614–1620PubMedGoogle Scholar
  72. Purvis K, Landgren BM, Cekan Z, Diczfalusy E (1975) Indices of gonadal function in the human male. II. Seminal plasma levels of steroids in normal and pathological conditions. Clin Endocrinol (Oxf) 4:247–258Google Scholar
  73. Rogers BJ, Bentwood B (1982) Capacitation, acrosome reaction and fertilization. In: Zaneveld LJD, Chatterton RT (eds) Biochemistry of mammalian reproduction. Wiley, New York, pp 203–230Google Scholar
  74. Rose NR, Hjort T, Rumke P, Harper MJK, Vyazov O (1976) Techniques for detection of iso-and auto-antibodies to spermatozoa. Clin Exp Immunol 23:175–199Google Scholar
  75. Rothschild (1953) A new method of measuring sperm speeds. Nature 171:512–513PubMedGoogle Scholar
  76. Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AMA (2000) WHO manual for the standardized investigation, diagnosis and management of the infertile male. Cambridge University Press, CambridgeGoogle Scholar
  77. Sylvester SR, Griswold MD (1984) Localization of transferrin and transferrin receptors in rat testes. Biol Reprod 31:195–203PubMedGoogle Scholar
  78. Tyler JP, Pryor JP, Collins WP (1981) Heterologous ovum penetration by human spermatozoa. J Reprod Fertil 63:499–508PubMedGoogle Scholar
  79. van den Saffele J, Vermeulen L, Schoonjans F, Comhaire FH (1992) Evaluation of the hypo-osmotic swelling test in relation with advanced methods of semen analysis. Andrologia 24:213–217PubMedGoogle Scholar
  80. Verhoeven G, Steeno O (1979) Evidence for the prostatic origin of gamma-glutamyltranspeptidase activity in human semen. Andrologia 11:163–167PubMedGoogle Scholar
  81. Wang C, Leung A, Tsoi WL, Leung J, Ng V, Lee KF, Chan SY (1991) Computer-assisted assessment of human sperm morphology: usefulness in predicting fertilizing capacity of human spermatozoa. Fertil Steril 55:989–993PubMedGoogle Scholar
  82. WHO (1987) WHO laboratory manual of the examination of human semen and sperm-cervical mucus interaction. Cambridge University Press, CambridgeGoogle Scholar
  83. WHO (1999) WHO laboratory manual of the examination of human semen and sperm-cervical mucus interaction. Cambridge University Press, CambridgeGoogle Scholar
  84. Williams WW, Savage A (1925) Observations on the seminal micropathology of bulls. Cornell Vet 15:353–375Google Scholar
  85. Zalata A, Hafez T, Verdonck L, Vermeulen L, Comhaire F (1995) Androgens in seminal plasma: markers of the surface epithelium of the male reproductive tract. Int J Androl 18:271–277PubMedGoogle Scholar
  86. Zalata AA, Christophe AB, Depuydt CE, Schoonjans F, Comhaire FH (1998) The fatty acid composition of phospholipids of spermatozoa from infertile patients. Mol Hum Reprod 4:111–118PubMedGoogle Scholar
  87. Zinkham WH, Blanco A, Clowry LJ Jr. (1964) An unusual isozyme of lactate dehydrogenase in mature testes: localization, ontogeny, and kinetic properties. Ann NY Acad Sci 121:571–588PubMedGoogle Scholar

Bibliografia

  1. Berkovitz A, Eltes F, Yaari S, Katz N, Barr I, Fishman A, Bartoov B (2004) The morphological normalcy of the sperm nucleus and pregnancy rate of intracytoplasmic injection with morphologically selected sperm. Hum Reprod 20:185–190PubMedGoogle Scholar
  2. Bonde JP, Ernst E, Jensen TK, Hjollund NH, Kolstad H, Henriksen TB, Scheike T, Giwercman A, Olsen J, Skakkebaek NE (1998) Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet 352:1172–1177PubMedGoogle Scholar
  3. Bonduelle M, van Assche E, Joris H, Keymolen K, Devroey P, van Steirteghem A, Liebaers I (2002) Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod 17:2600–2614PubMedGoogle Scholar
  4. Carrell DT, Wilcox AL, Lowy L, Peterson CM, Jones KP, Erickson L, Campbell B, Branch DW, Hatasaka HH (2003) Elevated sperm chromosome aneuploidy and apoptosis in patients with unexplained recurrent pregnancy loss. Obstet Gynecol 101:1229–1235PubMedGoogle Scholar
  5. Check M, Check JK, Summers-Chase D, Swenson K, Yuan W (2003) An evaluation of the efficacy of in vitro fertilization with intracytoplasmic sperm injection for sperm with low hypoosmotic swelling test scores and poor morphology. J Assis Reprod Genet 20:182–185Google Scholar
  6. Chemes HE, Rawe VY (2003) Sperm pathology: a step beyond descriptive morphology. Origin, characterization and fertility potential of abnormal sperm phenotypes in infertile men. Hum Reprod Update 9:405–428PubMedGoogle Scholar
  7. Coetzee K, Kruger TF, Lombard CJ (1998) Predictive value of normal sperm morphology: a structured literature review. Hum Reprod Update 4:73–82PubMedGoogle Scholar
  8. Comhaire F, Schoonjans F, Vermeulen L, De Clerq N (1994) Methodological aspects of sperm morphology evaluation: comparison between strict and liberal criteria. Fertil Steril 62:857–861PubMedGoogle Scholar
  9. De Vos A, van de Velde H, Joris H, Verheyen G, Devroey P, van Steirteghem A (2003) Influence of individual sperm morphology on fertilization, embryo morphology, and pregnancy outcome of intracytoplasmic sperm injection. Fertil Steril 79:42–48PubMedGoogle Scholar
  10. Eliasson R (1971) Standards for investigation of human semen. Andrologia 3:49Google Scholar
  11. Franken DR, Barendson R, Kruger TF (2000) A continuous quality control (CQC) program for strict sperm morphology. Fertil Steril 74:721–724PubMedGoogle Scholar
  12. Gomez E, Buckingham D, Brindle J, Lanzafame F, Irvine DS, Aitken RJ (1996) Development of an image analysis system to monitor the retention of residual cytoplasm by human spermatozoa: correlation with biochemical markers of the cytoplasmic space, oxidative stress and sperm function. J Androl 17:276–287PubMedGoogle Scholar
  13. Günalp S, Onculoglu C, Gurgan T Kruger TF, Lombard CJ (2001) A study of semen parameters with emphasis on sperm morphology in a fertile population: an attempt to develop clinical thresholds. Hum Reprod 16:110–114PubMedGoogle Scholar
  14. Guzick DS, Overstreet JW, Factor-Litwack P, Brazil CK, Nakajima ST, Coutifaris C, Carson SA, Cisneros P, Steinkampf MP, Hill JA, Xu D, Vogel DL (2001) Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 345:1388–1393PubMedGoogle Scholar
  15. Haidl (2002) Management strategies for male factor infertility. Drugs 62:1741–1753PubMedGoogle Scholar
  16. Haidl G, Badura B, Hinsch KD, Ghyczy M, Gareiss J, Schill WB (1993) Disturbances of sperm flagella due to failure of epididymal maturation and their possible relationship to phospholipids. Hum Reprod 8:1070–1073PubMedGoogle Scholar
  17. Hauser R, Yogev L, Botchan A, Lessing JB, Paz G, Yavetz H (2001) Intrauterine insemination in male factor subfertility: significance of sperm motility and morphology assessed by strict criteria. Andrologia 33:13–17PubMedGoogle Scholar
  18. Henkel R, Maass G, Bödeker R-H, Scheibelhut C, Stalf T, Mehnert C, Schuppe HC, Jung A, Schill WB (2005) Sperm function and assisted reproduction technology. Reprod Med Biol 4:7–30Google Scholar
  19. Hofmann N, Haider SG (1985) New results in the morphologic diagnosis of spermatogenesis disorders (German). Gynäkologe 18:70–80PubMedGoogle Scholar
  20. Hofmann N, Hilscher B (1991) Use of aniline blue to assess chromatin condensation in morphologically normal spermatozoa in normal and infertile men. Hum Reprod 6:979–982PubMedGoogle Scholar
  21. Hofmann N, Hilscher B, Möhrchen B, Schuppe HC, Bielfeld P (1995) Comparative studies on various modes of classification of morphology of sperm heads and results in in vitro fertilization-a preliminary report. Andrologia 27:19–23PubMedGoogle Scholar
  22. Johanisson E, Campana A, Luthi R, de Agostini A (2000) Evaluation of “round cells” in semen analysis: a comparative study. Hum Reprod 6:404–412Google Scholar
  23. Kruger TF, Franken DR (2004) Atlas of human sperm morphology evaluation. Taylor and Francis, LondonGoogle Scholar
  24. Kruger TF, Menkveld R, Stander FSH, Lombard CJ, van der Merwe JP, van Zyl JA, Smith K (1986) Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil Steril 46:1118–1123PubMedGoogle Scholar
  25. Kruger TF, Acosta AA, Simmons KF, Swanson RJ, Matta JF, Oehninger S (1988) Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril 49:112–117PubMedGoogle Scholar
  26. Lee RK, Hou JW, Ho HY, Hwu YM, Lin MH, Tsai YC, Su JT (2002) Sperm morphology analysis using strict criteria as a prognostic factor in intrauterine insemination. Int J Androl 25:277–280PubMedGoogle Scholar
  27. Martin RH, Greene C, Rademaker AW (2003) Sperm chromosome aneuploidy analysis in a man with globozoospermia. Fertil Steril 79 [Suppl 3]: 1662–1664PubMedGoogle Scholar
  28. Menkveld R, Stander F, Kotze T, Kruger TF, van Zyl JA (1990) The evaluation of morphological characteristics of human spermatozoa according to stricter criteria. Hum Reprod 5:586–592PubMedGoogle Scholar
  29. Menkveld R, Laquet F, Kruger TF, Lombard CJ, Sanchez Sarmiento CA, de Villiers A (1997) Effects of different staining and washing procedures on the results of human sperm morphology evaluation by manual and computerised methods. Andrologia 29:1–7PubMedGoogle Scholar
  30. Meschede D, Keck C, Zander M, Cooper TG, Yeung C, Nieschlag E (1993) Influence of three different preparation techniques on the results of human sperm morphology analysis. Int J Androl 16:362–369PubMedGoogle Scholar
  31. Nagy ZP, Liu J, Joris H, Verheyen G, Tournaye H, Camus M, Derde MC, Devroey P, van Steirteghem AC (1995) The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum Reprod 10:1123–1129PubMedGoogle Scholar
  32. Novero V, Camus M, Tournaye H, Smitz J, Verheye G, Joris H, Derde MP, van Steirteghem A, Devroey (1997) Relationship between serum follicle stimulating hormone in the male and standard sperm parameters, and the results of intracytoplasmic sperm injection. Hum Reprod 12:59–63PubMedGoogle Scholar
  33. Ombelet W, Menkveld R, Kruger TF, Steeno O (1995) Sperm morphology assessment: historical review in relation to fertility. Hum Reprod Update 1:543–557PubMedGoogle Scholar
  34. Ombelet W, Bosmans E, Janssen M et al (1997) Semen parameters in a fertile versus subfertile population: a need for change in the interpretation of semen testing. Hum Reprod 12:987–993PubMedGoogle Scholar
  35. Razavi S, Nasr-Esfahani MH, Mardani M, Mafi A, Moghdam A (2003) Effect of human sperm chromatin anomalies on fertilization outcome post-ICSI. Andrologia 35:238–243PubMedGoogle Scholar
  36. Salumets A, Suikkari AM, Möls T, Söderström-Anttila V, Tuuri T (2002) Influence of oocytes and spermatozoa on early embryonic development. Fertil Steril 78:1082–1087PubMedGoogle Scholar
  37. Slama R, Eustache F, Ducot B, Jensen TK, Joergensen N, Horte A, Irvine S, Suominen J, Andersen AG, Auger J, Vierula M, Toppari J, Andersen AN, Keiding N, Skakkebaek NE, Spira A, Jouannet P (2002) Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum Reprod 17:503–515PubMedGoogle Scholar
  38. Van Waart J, Kruger TF, Lombard CJ, Ombelet W (2001) Predictive value of normal sperm morphology in intrauterine insemination (IUI): a structured literature review. Hum Reprod Update 7:495–500PubMedGoogle Scholar
  39. Vicari E, de Palma A, Burrello N, Longo G, Grazioso C, Barone N, Zahi M, D’Agata R, Calogero AE (2003) Absolute polymorphic teratozoospermia in patients with oligo-asthenozoospermia is associated with an elevated sperm aneuploidy rate. J Androl 24:598–603PubMedGoogle Scholar
  40. Villegas J, Schulz M, Vallejos V, Henkel R, Miska W, Sanchez R (2002) Indirect immunofluorescence using monoclonal antibodies for the detection of leukocytospermia: comparison with peroxidase staining. Andrologia 34:69–73PubMedGoogle Scholar
  41. Wolff H (1995) The biologic significance of white blood cells in semen. Fertil Steril 63:1143–1157PubMedGoogle Scholar
  42. World Health Organization (1992) WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 3rd edn. Cambridge University Press, CambridgeGoogle Scholar
  43. World Health Organization (1999) WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 4th edn. Cambridge University Press, CambridgeGoogle Scholar
  44. Zinaman MJ, Brown CC, Selevan SG, Clegg ED (2000) Semen quality and human fertility. A prospective study with healthy couples. J Androl 21:145–153PubMedGoogle Scholar

Bibliografia

  1. Bowie WR, Pollock HM, Forsyth PS, Floyd JF, Alexander ER, Wang SP, Holmes KK (1977) Bacteriology of the urethra in normal men and men with nongonococcal urethritis. J Clin Microbiol 6:482–488PubMedGoogle Scholar
  2. British Andrology Society (1999) British Andrology Society guidelines for the screening of semen donors for donor insemination. Hum Reprod 14:1823–1826PubMedGoogle Scholar
  3. Brunner H, Weidner W, Schiefer HG (1983) Studies on the role of Ureaplasma urealyticum and Mycoplasma hominis in prostatitis. J Infect Dis 147:807–813PubMedGoogle Scholar
  4. Craig JM, Barratt CLR, Kinghorn GR (1977) Semen donors and STD screening. Genitourin Med 73:280–283Google Scholar
  5. Drach GW, Fair WR, Meares EM, Stamey TA (1978) Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? J Urol 120:266PubMedGoogle Scholar
  6. Dupin N, Bijaoui G, Schwarzinger M, Ernault P, Gerhardt P, Jdid R, Hilab S, Pantoja C, Buffet M, Escande JP, Costa JM (2003) Detection and quantification of Mycoplasma genitalium in male patients with urethritis. Clin Infect Dis 37:602–605PubMedGoogle Scholar
  7. Eggert-Kruse W, Rohr G, Ströck W, Pohl S, Schwalbach B, Runnebaum B (1995) Anaerobes in ejaculates of subfertile men. Hum Reprod Update 1:462–478PubMedGoogle Scholar
  8. Friberg J, Gleicher N, Suarez M, Confino E (1985) Chlamydia attached to spermatozoa. J Infect Dis 152:854PubMedGoogle Scholar
  9. Funke G, Bernard KA, Bucher C, Pfyffer GE, Collins MD (1995) Corynebacterium glucuronolyticum sp. nov. isolated from male patients with genitourinary infections. Med Microbiol Lett 4:204–215Google Scholar
  10. Hawkins DA, Fontaine EAR, Thomas BJ, Boustouller YL, Taylor-Robinson D (1988) The enigma of non-gonococcal urethritis: role for Bacteroides ureolyticus. Genitourin Med 64: 11–13Google Scholar
  11. Howell CL, Miller MJ, Bruckner DA (1986) Elimination of toxicity and enhanced cytomegalovirus detection in cell cultures inoculated with semen from patients with acquired immunodeficiency syndrome. J Clin Microbiol 24:657–660PubMedGoogle Scholar
  12. Isenberg HD (ed) (1998) Essential procedures for clinical microbiology. ASM Press, Washington DCGoogle Scholar
  13. Jensen JS, Orsum R, Dohn B, Uldum S, Worm AW, Lind K (1993) Mycoplasma genitalium: a cause of male urethritis? Genitourin Med 69:265–269PubMedGoogle Scholar
  14. Jensen JS, Hansen HT, Lind K (1996) Isolation of Mycoplasma genitalium strains from the male urethra. J Clin Microbiol 34:286–291PubMedGoogle Scholar
  15. Jensen IP, Fogh H, Prag J (2003) Diagnosis of Chlamydia trachomatis infections in a sexually transmitted disease clinic: evaluation of a urine sample tested by enzyme immunoassay and polymerase chain reaction in comparison with a cervical and/or a urethral swab tested by culture and polymerase chain reaction. Clin Microbiol Infect 9:194–201PubMedGoogle Scholar
  16. Kashube ADM, Dyer JR, Kramer LM, Raasch RH, Eron JJ, Cohen MS (1999) Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1. Antimicrob Agents Chemother 43:1817–1826Google Scholar
  17. Kharsany ABM, Hoosen AA, Kiepiela P, Naicker T, Sturm AW (1996) Culture of Calymmatobacterium granulomatis. Clin Infect Dis 22:391PubMedGoogle Scholar
  18. Krieger JN, Egan KJ, Ross SO, Jacobs R, Berger RE (1996a) Chronic pelvic pains represent the most prominent urogenital symptoms of chronic prostatitis. Urology 48:715–722PubMedGoogle Scholar
  19. Krieger JN, Riley DE, Roberts MC, Berger RE (1996b) Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J Clin Microbiol 34:3120–3128PubMedGoogle Scholar
  20. Krieger JN, Jacobs RR, Ross SO (2000) Does the chronic prostatitis/pelvic pain syndrome differ from non bacterial prostatitis and prostatodynia? J Urol 164:1554–1558PubMedGoogle Scholar
  21. Liesnard CA (1998) Screening of semen donors for infectious diseases. Hum Reprod 13 [Suppl 2]:12–24PubMedGoogle Scholar
  22. Ludwig M, Kümmel C, Schroeder-Printzen I, Ringert RH, Weidner W (1998) Evaluation of seminal plasma parameters in patients with chronic prostatitis or leukocytospermia. Andrologia 30 [Suppl. 1]:41–47PubMedGoogle Scholar
  23. Mascola L, Guinan ME (1986) Screening to reduce transmission of sexually transmitted diseases in semen used for artificial insemination. New Engl J Med 314:1354–1359PubMedGoogle Scholar
  24. Mestecky J, Fultz PN (1999) Mucosal immune system of the human genital tract. J Infect Dis 179 [Suppl 3]:S470–S474PubMedGoogle Scholar
  25. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) (2003) Manual of clinical microbiology, 8th edn. ASM Press, Washington DCGoogle Scholar
  26. Nickel JC (1998) Effective office management of chronic prostatitis. Urol Clin North Am 25:677–684PubMedGoogle Scholar
  27. Riegel P, Ruimy R, de Briel D, Prévost G, Jehl F, Bimet F, Christen R, Monteil H (1995) Corynebacterium seminale sp. nov., a new species associated with genital infections in male patients. J Clin Microbiol 33:2244–2249PubMedGoogle Scholar
  28. Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AMA (2000) WHO manual for the standardized investigation, diagnosis and management of the infertile male. Cambridge University Press, CambridgeGoogle Scholar
  29. Sandys GH (1960) A new method of preventing swarming of Proteus sp. with a description of a new medium suitable for use in routine laboratory practice. J Med Lab Technol 17:224–233PubMedGoogle Scholar
  30. Schiefer HG (1998) Microbiology of male urethroadnexitis: Diagnostic procedures and criteria for aetiologic classification. Andrologia 30 [Suppl 1]:7–13PubMedGoogle Scholar
  31. Schiefer HG, Jantos C, Weidner W (1993) Prostatitis syndrome. Cytological and microbiological procedures for diagnosis and classification. Med Microbiol Lett 2:403–410Google Scholar
  32. Tanner MA, Shoskes D, Shahed A, Pace NR (1999) Prevalence of corynebacterial 16 S rRNA sequences in patients with bacterial and “non bacterial” prostatitis. J Clin Microbiol 37:1863–1870PubMedGoogle Scholar
  33. Taylor-Robinson D (1996) Infections due to species of Mycoplasma and Ureaplasma: an update. Clin Infect Dis 23:671–684PubMedGoogle Scholar
  34. Tuuminen T, Palomäki P, Paavonen J (2000) The use of serologic tests for the diagnosis of chlamydial infections. J Microbiol Methods 42:265–279PubMedGoogle Scholar
  35. Weidner W, Schiefer HG, Garbe C (1987) Acute nongonococcal epididymitis. Aetiological and therapeutic aspects. Drugs 34 [Suppl. 1]:111–117PubMedGoogle Scholar
  36. Weidner W, Schiefer HG, Krauss H, Jantos C, Friedrich HJ, Altmannsberger M (1991) Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1461 patients. Infection 19 [Suppl. 3]:S119–S125PubMedGoogle Scholar
  37. Weidner W, Madsen PO, Schiefer HG (eds) (1994) Prostatitis. Etiopathology, diagnosis and therapy. Springer, Berlin Heidelberg New YorkGoogle Scholar
  38. World Health Organization (1999) WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 4th edn. Cambridge University Press, CambridgeGoogle Scholar

Bibliografia

  1. Belanger A, Candas B, Dupont A, Cusan L, Diamond P, Gomez JL, Labrie F (1994) Changes in serum concentrations of conjugated and unconjugated steroids in 40-to 80-year-old men. J Clin Endocrinol Metab 79:1086–1090PubMedGoogle Scholar
  2. Bhasin S, Bagatell CJ, Bremner WJ, Plymate SR, Tenover JL, Korenman SG, Nieschlag E (1998) Issues in testosterone replacement in older men. J Clin Endocrinol Metab 83: 3435–3448PubMedGoogle Scholar
  3. Brennemann W, Sommer L, Stoffel-Wagner B, Bidlingmaier F, Klingmüller D (1994) Secretion pattern of immunoreactive inhibin in men. Eur J Endocrinol 131:273–279PubMedGoogle Scholar
  4. Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD (2003) Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf) 58:710–717Google Scholar
  5. Earle CM, Stuckey BG (2003) Biochemical screening in the assessment of erectile dysfunction: what tests decide future therapy? Urology 62:727–731PubMedGoogle Scholar
  6. Gad YZ, Nasr H, Mazen I, Salah N, el-Ridi R (1997) 5 Alphareductase deficiency in patients with micropenis. J Inherit Metab Dis 20:95–101PubMedGoogle Scholar
  7. Groome NP, Illingworth PJ, O’Brien M, Pai R, Rodger FE, Mather JP, McNeilly AS (1996) Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81:1401–1405PubMedGoogle Scholar
  8. Hammond GL, Nisker JA, Jones LA, Siiteri PK (1980) Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. J Biol Chem 255:5023–5026PubMedGoogle Scholar
  9. Hiroi N, Ichijo T, Shimojo M, Ueshiba H, Tsuboi K, Miyachi Y (2001) Pituitary apoplexy caused by luteinizing hormonereleasing hormone in prolactin-producing adenoma. Intern Med 40:747–750PubMedGoogle Scholar
  10. Jensen TK, Andersson AM, Hjollund NH, Scheike T, Kolstad H, Giwercman A, Henriksen TB, Ernst E, Bonde JP, Olsen J, McNeilly A, Groome NP, Skakkebaek NE (1997) Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab 82:4059–4063PubMedGoogle Scholar
  11. Jungmann E, Trautermann C (1994) [The status of the gonadotropin releasing hormone test in differential diagnosis of delayed puberty in adolescents over 14 years of age.] Med Klin (Munich) 89:529–533Google Scholar
  12. Kinon BJ, Gilmore JA, Liu H, Halbreich UM (2003) Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials. Psychoneuroendocrinology 28 [Suppl 2]:69–82PubMedGoogle Scholar
  13. Klingmüller D, Haidl G (1997) Inhibin B in men with normal and disturbed spermatogenesis. Hum Reprod 12:2376–2378PubMedGoogle Scholar
  14. Klingmüller D, Dewes W, Krahe T, Brecht G, Schweikert HU (1987) Magnetic resonance imaging of the brain in patients with anosmia and hypothalamic hypogonadism (Kallmann’s syndrome). J Clin Endocrinol Metab 65:581–584PubMedGoogle Scholar
  15. Knorr D, Beckmann D, Bidlingmaier F, Helmig FJ, Sippell WG (1979) Plasma testosterone in male puberty. II. hCG stimulation test in boys with hypospadia. Acta Endocrinol (Copenh) 90:365–371Google Scholar
  16. Kubini K, Zachmann M, Albers N, Hiort O, Bettendorf M, Wolfle J, Bidlingmaier F, Klingmüller D (2000) Basal inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys. J Clin Endocrinol Metab 85:134–138PubMedGoogle Scholar
  17. Molitch ME (1992) Pathologic hyperprolactinemia. Endocrinol Metab Clin North Am 21:877–901PubMedGoogle Scholar
  18. Oseko F, Oka N, Furuya H, Morikawa K (1988) Effects of chronic sulpiride-induced hyperprolactinemia on plasma testosterone and its responses to hCG in normal men. J Androl 9:231–233PubMedGoogle Scholar
  19. Pardridge WM (1988) Selective delivery of sex steroid hormones to tissues by albumin and by sex hormone-binding globulin. Oxf Rev Reprod Biol 10:237–292PubMedGoogle Scholar
  20. Pavord SR, Girach A, Price DE, Absalom SR, Falconer-Smith J, Howlett TA (1992) A retrospective audit of the combined pituitary function test, using the insulin stress test, TRH and GnRH in a district laboratory. Clin Endocrinol (Oxf) 36:135–139Google Scholar
  21. Pierik FH, Vreeburg JT, Stijnen T, De Jong FH, Weber RF (1998) Serum inhibin B as a marker of spermatogenesis. J Clin Endocrinol Metab 83:3110–3114PubMedGoogle Scholar
  22. Schlosser R, Grunder G, Anghelescu I, Hillert A, EwaldGrunder S, Hiemke C, Benkert O (2002) Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels. Neuropsychobiology 46:33–40PubMedGoogle Scholar
  23. Snyder PJ, Rudenstein RS, Gardner DF, Rothman JG (1979) Repetitive infusion of gonadotropin-releasing hormone distinguishes hypothalamic from pituitary hypogonadism. J Clin Endocrinol Metab 48:864–868PubMedGoogle Scholar
  24. Steckelbroeck S, Heidrich DD, Stoffel-Wagner B, Hans VH, Schramm J, Bidlingmaier F, Klingmüller D (1999) Characterization of aromatase cytochrome P450 activity in the human temporal lobe. J Clin Endocrinol Metab 84:2795–2801PubMedGoogle Scholar
  25. St-Jean E, Blain F, Comtois R (1996) High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. Clin Endocrinol (Oxf) 44:305–309Google Scholar
  26. Taieb J, Benattar C, Birr AS, Lindenbaum A (2002) Limitations of steroid determination by direct immunoassay. Clin Chem 48:583–585PubMedGoogle Scholar
  27. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C, Boudou P (2003) Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatographymass spectrometry in sera from 116 men, women, and children. Clin Chem 49:1381–1395PubMedGoogle Scholar
  28. Vermeulen A, Verdonck G (1992) Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. J Clin Endocrinol Metab 74:939–942PubMedGoogle Scholar
  29. Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666–3672PubMedGoogle Scholar
  30. Vierhapper H (1985) LH-RH stimulated LH secretion in human endocrine disease. Acta Endocrinol Suppl (Copenh) 269:3–25Google Scholar
  31. Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS (2004) Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 89:534–543PubMedGoogle Scholar
  32. Weinstein RL, Kelch RP, Jenner MR, Kaplan SL, Grumbach MM (1974) Secretion of unconjugated androgens and estrogens by the normal and abnormal human testis before and after human chorionic gonadotropin. J Clin Invest 53:1–6PubMedGoogle Scholar
  33. Winters SJ, Plant TM (1999) Partial characterization of circulating inhibin-B and pro-alphaC during development in the male rhesus monkey. Endocrinology 140:5497–5504PubMedGoogle Scholar

Bibliografia

  1. Abe M, Manola JB, Oh WK, Parslow DL, George DJ, Austin CL, Kantoff PW (2004) Plasma levels of heat shock protein 70 in patients with prostate cancer: a potential biomarker for prostate cancer. Clin Prostate Cancer 3:49–53PubMedGoogle Scholar
  2. Abelev GI, Eraiser TL (1999) Cellular aspects of alpha-fetoprotein reexpression in tumors. Semin Cancer Biol 9:95–107PubMedGoogle Scholar
  3. Abelev GI, Perova SD, Khramkova NI, Postnikova ZA, Irlin IS (1963) Production of embryonal alpha-globulin by transplantable mouse hepatomas. Transplantation 1:174–180PubMedGoogle Scholar
  4. Bangma CH, Verhagen PC (2000) Blood and serum substances for markers of prostate cancer. Microsc Res Tech 51:430–435PubMedGoogle Scholar
  5. Barbatzas C, Dellis A, Grivas I, Trakas N, Ekonomou A, Kostakopoulos A (2004) Colonoscopy effects on serum prostate specific antigen levels. Int Urol Nephrol 36:203–206PubMedGoogle Scholar
  6. Baumgart Y, Otto A, Schafer A, Usbeck E, Cott C, Schott A, Tornack M, Wenzel A, Mossie A, Birkenmeier G (2004) Characterization of novel monoclonal antibodies for prostatespecific antigen (PSA) with potency to recognize PSA bound to alpha2-macroglobulin. Clin Chem 51:84–92PubMedGoogle Scholar
  7. Beck SD, Patel MI, Sheinfeld J (2004) Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors. J Urol 171:168–171PubMedGoogle Scholar
  8. Bergh A, Cajander S (1990) Immunohistochemical localization of inhibin-alpha in the testes of normal men and in men with testicular disorders. Int J Androl 13:463–469PubMedGoogle Scholar
  9. Bergstrand CG, Czar B (1956) Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest 8:174PubMedGoogle Scholar
  10. Black MH, Diamandis EP (2000) The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast. Breast Cancer Res Treat 59:1–14PubMedGoogle Scholar
  11. Brown CW, Houston-Hawkins DE, Woodruff TK, Matzuk MM (2000) Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions. Nat Genet 25:453–457PubMedGoogle Scholar
  12. Canto EI, Singh H, Shariat SF, Lamb DJ, Mikolajczyk SD, Linton HJ, Rittenhouse HG, Kadmon D, Miles BJ, Slawin KM (2004) Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer. Urology 63:905–910PubMedGoogle Scholar
  13. Cartledge JJ, Thompson D, Verril H, Clarkson P, Eardley I (1999) The stability of free and bound prostate-specific antigen. BJU Int 84:810–814PubMedGoogle Scholar
  14. Catalona WJ (1996) Clinical utility of measurements of free and total prostate-specific antigen (PSA): a review. Prostate Suppl 7:64–69Google Scholar
  15. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, de Kernion JB, Ratliff TL, Kavoussi LR, Dalkin BL et al (1994) Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 151:1283–1290PubMedGoogle Scholar
  16. Christensson A, Laurell CB, Lilja H (1990) Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 194:755–763PubMedGoogle Scholar
  17. Christiansen M, Hogdall CK, Brihmer C (1995) Alpha-fetoprotein and the acute phase response. A study using acute pelvic inflammatory disease as a model system. Clin Chim Acta 235:71–79PubMedGoogle Scholar
  18. Christiansen M, Hogdall CK, Andersen JR, Norgaard-Pedersen B (2001) Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals. Scand J Clin Lab Invest 61:205–215PubMedGoogle Scholar
  19. Chybowski FM, Bergstralh EJ, Oesterling JE (1992) The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study. J Urol 148:83–86PubMedGoogle Scholar
  20. Cleutjens KB, van Eekelen CC, van der Korput HA, Brinkmann AO, Trapman J (1996) Two androgen response regions cooperate in steroid hormone regulated activity of the prostatespecific antigen promoter. J Biol Chem 271:6379–6388PubMedGoogle Scholar
  21. Cole LA, Sutton JM (2004) Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer. J Reprod Med 49:545–553PubMedGoogle Scholar
  22. Cooner WH, Mosley BR, Rutherford CL Jr, Beard JH, Pond HS, Terry WJ, Igel TC, Kidd DD (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143:1146–1152PubMedGoogle Scholar
  23. Cooper EH, Whelan P, Purves D (1994) Bone alkaline phosphatase and prostate-specific antigen in the monitoring of prostate cancer. Prostate 25:236–242PubMedGoogle Scholar
  24. Crawford ED, Schutz MJ, Clejan S, Drago J, Resnick MI, Chodak GW, Gomella LG, Austenfeld M, Stone NN, Miles BJ et al (1992) The effect of digital rectal examination on prostatespecific antigen levels. J Am Med Assoc 267:2227–2228Google Scholar
  25. David A, Mabjeesh N, Azar I, Biton S, Engel S, Bernstein J, Romano J, Avidor Y, Waks T, Eshhar Z, Langer SZ, Lifschitz Mercer B, Matzkin H, Rotman G, Toporik A, Savitsky K, Mintz L (2002) Unusual alternative splicing within the human kallikrein genes KLK2 and KLK3 gives rise to novel prostate-specific proteins. J Biol Chem 277:18084–18090PubMedGoogle Scholar
  26. de Takats PG, Jones SR, Penn R, Cullen MH (1996) Alphafoetoprotein heterogeneity: what is its value in managing patients with germ cell tumours?. Clin Oncol (R Coll Radiol) 8:323–326Google Scholar
  27. de Vries SH, Raaijmakers R, Kranse R, Blijenberg BG, Schroder FH (2004) Prostate cancer characteristics and prostate specific antigen changes in screening detected patients initially treated with a watchful waiting policy. J Urol 172:2193–2196PubMedGoogle Scholar
  28. Derakhshani P, Klotz T, Heidenreich A, Engelmann U (1999) Diffuse metastasized testicular teratoma and paraneoplastic thyreotoxicosis. Case report and literature review. Urol Int 63:265–267PubMedGoogle Scholar
  29. Diamandis EP, Yousef GM (2002) Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem 48:1198–1205PubMedGoogle Scholar
  30. Djavan B, Remzi M, Zlotta A, Seitz C, Snow P, Marberger M (2002) Novel artificial neural network for early detection of prostate cancer. J Clin Oncol 20:921–929PubMedGoogle Scholar
  31. Doherty AP, Bower M, Smith GL, Miano R, Mannion EM, Mitchell H, Christmas TJ (2000) Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival. Br J Cancer 83:1432–1436PubMedGoogle Scholar
  32. Douglas TH, Morgan TO, McLeod DG, Moul JW, Murphy GP, Barren R 3rd, Sesterhenn IA, Mostofi FK (1997) Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients. Cancer 80:107–114PubMedGoogle Scholar
  33. Ebi H, Nakata M, Tahara M, Igarashi T, Kawada K, Itoh K, Ueda R, Minami H (2003) Extragonadal germ cell tumors in Japan. Cancer Sci 94:1107–1111PubMedGoogle Scholar
  34. Ellis WJ, Chetner MP, Preston SD, Brawer MK (1994) Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J Urol 152:1520–1525PubMedGoogle Scholar
  35. Ellis WJ, Vessella RL, Noteboom JL, Lange PH, Wolfert RL, Rittenhouse HG (1997) Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostatespecific antigen assay. Urology 50:573–579PubMedGoogle Scholar
  36. Finne P, Auvinen A, Aro J, Juusela H, Maattanen L, Rannikko S, Hakama M, Tammela TL, Stenman UH (2002) Estimation of prostate cancer risk on the basis of total and free prostatespecific antigen, prostate volume and digital rectal examination. Eur Urol 41:619–626PubMedGoogle Scholar
  37. Friedland SJ, Aronson WJ, Kane CJ, Terris MK, Presti JC Jr, Trock B, Amling CL (2004) Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels. Cancer 101:748–753Google Scholar
  38. Gabant P, Forrester L, Nichols J, Van Reeth T, De Mees C, Pajack B, Watt A, Smitz J, Alexandre H, Szpirer C, Szpirer J (2002) Alpha-fetoprotein, the major fetal serum protein, is not essential for embryonic development but is required for female fertility. Proc Natl Acad Sci USA 99:12865–12870PubMedGoogle Scholar
  39. Gels ME, Marrink J, Visser P, Sleijfer DT, Droste JH, Hoekstra HJ, Andrews PW, Schraffordt Koops H (1997) Importance of a new tumor marker TRA-1 — 60 in the follow-up of patients with clinical stage I nonseminomatous testicular germ cell tumors. Ann Surg Oncol 4:321–327PubMedGoogle Scholar
  40. Germa JR, Llanos M, Tabernero JM, Mora J (1993) False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors. Cancer 72:2491–2494PubMedGoogle Scholar
  41. Gillott DJ, Iles RK, Chard T (1996) The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer 73:323–326PubMedGoogle Scholar
  42. Giralt SA, Dexeus F, Amato R, Sella A, Logothetis C (1992) Hyperthyroidism in men with germ cell tumors and high levels of beta-human chorionic gonadotropin. Cancer 69:1286–1290PubMedGoogle Scholar
  43. Goodarzi MO, Van Herle AJ (2000) Thyrotoxicosis in a male patient associated with excess human chorionic gonadotropin production by germ cell tumor. Thyroid 10:611–619PubMedGoogle Scholar
  44. Greenberg F, Faucett A, Rose E, Bancalari L, Kardon NB, Mizejewski G, Haddow JE, Alpert E (1992) Congenital deficiency of alpha-fetoprotein. Am J Obstet Gynecol 167:509–511PubMedGoogle Scholar
  45. Gustafsson O, Mansour E, Norming U, Carlsson A, Tornblom M, Nyman CR (1998) Prostate-specific antigen (PSA), PSA density and ageadjusted PSA reference values in screening for prostate cancer — a study of a randomly selected population of 2,400 men. Scand J Urol Nephrol 32:373–377PubMedGoogle Scholar
  46. Gutman AB, Gutman EE (1938) An “acid” phosphatase occurring in the serum of patients with metastasising carcinoma of the prostate gland. J Clin Invest 17:473–478PubMedGoogle Scholar
  47. Haije WG, Talerman A, Boekestein-Tjahjadien HM, Baggerman L (1976) Alpha fetoprotein (AFP) in the serum of patients with germ cell tumors. The value of AFP determination for diagnosis and follow-up. Ned Tijdschr Geneeskd 120:855–859PubMedGoogle Scholar
  48. Hammerer P, Huland H (1994) Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 151:99–102PubMedGoogle Scholar
  49. Hara I, Yamada Y, Miyake H, Hara S, Gotoh A, Fujisawa M, Okada H, Arakawa S, Kamidono S (2002) Detection of betahuman chorionic gonadotropin expressing cells by nested reverse transcriptase-polymerase chain reaction in the peripheral blood stem cells of patients with advanced germ cell tumor. J Urol 167:1487–1491PubMedGoogle Scholar
  50. Harmenberg U, Koha M, Makiya R, Koshida K, Brismar B, Stigbrand T, Wahren B (1991) Identification and characterization of alkaline phosphatase isozymes in human colorectal adenocarcinomas. Tumour Biol 12:237–248PubMedGoogle Scholar
  51. Hautkappe AL, Lu M, Mueller H, Bex A, Harstrick A, Roggendorf M, Ruebben H (2000) Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA. Cancer Res 60:3170–3174PubMedGoogle Scholar
  52. Henttu P, Vihko P (1994) Prostate-specific antigen and human glandular kallikrein: two kallikreins of the human prostate. Ann Med 26:157–164PubMedGoogle Scholar
  53. Hernandez J, Thompson IM (2004) Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker. Cancer 101:894–904PubMedGoogle Scholar
  54. Heseltine D, White MC, Kendall-Taylor P, De Kretser DM, Kelly W (1989) Testicular enlargement and elevated serum inhibin concentrations occur in patients with pituitary macroadenomas secreting follicle stimulating hormone. Clin Endocrinol (Oxf) 31:411–423Google Scholar
  55. Horwich A, Peckham MJ (1986) Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis. Cancer Treat Rep 70:1329–1331PubMedGoogle Scholar
  56. Isshiki S, Akakura K, Komiya A, Suzuki H, Kamiya N, Ito H (2002) Chromogranin a concentration as a serum marker to predict prognosis after endocrine therapy for prostate cancer. J Urol 167:512–515PubMedGoogle Scholar
  57. Johnson PJ, Ho S, Cheng P, Chan A, Leung T, Yuen J (1995) Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing. Cancer 75:1663–1668PubMedGoogle Scholar
  58. Johnson PJ, Poon TC, Hjelm NM, Ho CS, Blake C, Ho SK (2000) Structures of disease-specific serum alpha-fetoprotein isoforms. Br J Cancer 83:1330–1337PubMedGoogle Scholar
  59. Jung K, Lein M, Brux B, Sinha P, Schnorr D, Loening SA (2000) Different stability of free and complexed prostate-specific antigen in serum in relation to specimen handling and storage conditions. Clin Chem Lab Med 38:1271–1275PubMedGoogle Scholar
  60. Khan MA, Partin AW (2004) Management of patients with an increasing prostate-specific antigen after radical prostatectomy. Curr Urol Rep 5:179–187PubMedGoogle Scholar
  61. Klezovitch O, Chevillet J, Mirosevich J, Roberts RL, Matusik RJ, Vasioukhin V (2004) Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 6:185–195PubMedGoogle Scholar
  62. Koistinen H, Paju A, Koistinen R, Finne P, Lovgren J, Wu P, Seppala M, Stenman UH (2002) Prostate-specific antigen and other prostatederived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3. Prostate 50:112–118PubMedGoogle Scholar
  63. Koshida K, Stigbrand T, Munck-Wikland E, Hisazumi H, Wahren B (1990) Analysis of serum placental alkaline phosphatase activity in testicular cancer and cigarette smokers. Urol Res 18:169–173PubMedGoogle Scholar
  64. Koshida K, Uchibayashi T, Yamamoto H, Hirano K (1996) Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma. Br J Urol 77:138–142PubMedGoogle Scholar
  65. Kovcin VN, Jelic SB, Ivanovic SM, Babovic NL (1997) Serum gonadotropin levels in patients with germ-cell tumors of the testis: interrelations, possible cross-reactions and interpretation of beta-HCG level. Int J Biol Markers 12:55–60PubMedGoogle Scholar
  66. Kuriyama M, Wang MC, Papsidero LD, Killian CS, Shimano T, Valenzuela L, Nishiura T, Murphy GP, Chu TM (1980) Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 40:4658–4662PubMedGoogle Scholar
  67. Lajer H, Daugaard G, Andersson AM, Skakkebaek NE (2002) Clinical use of serum TRA-1–60 as tumor marker in patients with germ cell cancer. Int J Cancer 100:244–246PubMedGoogle Scholar
  68. Li MS, Li PF, Yang FY, He SP, Du GG, Li G (2002) The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells. Cell Res 12:151–156PubMedGoogle Scholar
  69. Lintula S, Vesalainen S, Rannikko A, Zhang WM, Finne P, Stenman J, Stenman UH (2004) Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction. Scand J Clin Lab Invest 64:93–100PubMedGoogle Scholar
  70. Lippert MC, Javadpour N (1981) Lactic dehydrogenase in the monitoring and prognosis of testicular cancer. Cancer 48:2274–2278PubMedGoogle Scholar
  71. Lippert M, Papadopoulos N, Javadpour N (1981) Role of lactate dehydrogenase isoenzymes in testicular cancer. Urology 18:50–53PubMedGoogle Scholar
  72. Liu T, Bauskin AR, Zaunders J, Brown DA, Pankhurst S, Russell PJ, Breit SN, Panhurst S (2003) Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res 63:5034–5040PubMedGoogle Scholar
  73. Manetti L, Lupi I, Genovesi M, Morselli L, Grasso L, Nencetti C, Gasperi M, Bogazzi F, Bartalena L, Martino E (2004) Serum prostate-specific antigen concentration is increased in acromegalic women. J Endocrinol Invest 27:643–647PubMedGoogle Scholar
  74. Mann K, Saller B (1994a) Tumours of the prostate gland. In: Klapdor R (ed) Tumour markers in clinical oncology: an overview. Sorin Biomedica, Turin, pp 145–150Google Scholar
  75. Mann K, Saller B (1994b) Tumours of the testis. In: Klapdor R (ed) Tumour markers in clinical oncology: an overview. Sorin Biomedica, Turin, pp 151–156Google Scholar
  76. Mann K, Schneider N, Hoermann R (1986) Thyrotropic activity of acidic isoelectric variants of human chorionic gonadotropin from trophoblastic tumors. Endocrinology 118:1558–1566PubMedGoogle Scholar
  77. Masseyeff R, Bonet C, Drouet J, Sudaka P, Lalanne C (1974) Radioimmunoassay of alpha-fetoprotein. I. Technique and serum levels in the normal adult. Digestion 10:17–28PubMedGoogle Scholar
  78. Matsumura M, Bhatt AS, Andress D, Clegg N, Takayama TK, Craik CS, Nelson PS (2005) Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional scanning peptide libraries. Prostate 62:1–13PubMedGoogle Scholar
  79. Mazumdar M, Bajorin DF, Bacik J, Higgins G, Motzer RJ, Bosl GJ (2001) Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy. J Clin Oncol 19:2534–2541PubMedGoogle Scholar
  80. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, Oesterling JE (1995) Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 45:729–744PubMedGoogle Scholar
  81. Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP (1997) Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab 82:777–780PubMedGoogle Scholar
  82. Mikolajczyk SD, Catalona WJ, Evans CL, Linton HJ, Millar LS, Marker KM, Katir D, Amirkhan A, Rittenhouse HG (2004) Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer. Clin Chem 50:1017–1025PubMedGoogle Scholar
  83. Millan JL, Eriksson A, Stigbrand T (1982) A possible new locus of alkaline phosphatase expressed in human testis. Hum Genet 62:293–295PubMedGoogle Scholar
  84. Mohler JL, Siami PF, Flanigan RC (1987) False positive betahuman chorionic gonadotropin in testicular cancer. Urology 30:252–254PubMedGoogle Scholar
  85. Moller MB (1996) Association of testicular non-Hodgkin’s lymphomas with elevated serum levels of human chorionic gonadotropin-like material. Oncology 53:94–98PubMedGoogle Scholar
  86. Mora J, Gascon N, Tabernero JM, Germa JR, Gonzalez F (1995) Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseases. Eur J Cancer 31A:2239–2242PubMedGoogle Scholar
  87. Morote J, Lorente JA, Encabo G (1996) Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen. Cancer 78:2374–2378PubMedGoogle Scholar
  88. Morris MJ, Bosl GJ (2000) Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors. J Urol 163:796–801PubMedGoogle Scholar
  89. Nazeer T, Ro JY, Amato RJ, Park YW, Ordonez NG, Ayala AG (1998) Histologically pure seminoma with elevated alphafetoprotein: a clinicopathologic study of ten cases. Oncol Rep 5:1425–1429PubMedGoogle Scholar
  90. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr., Bruzek DJ, Rock RC, Brendler CB, Walsh PC (1988) Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139:766–772PubMedGoogle Scholar
  91. Olsson AY, Bjartell A, Lilja H, Lundwall A (2005) Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues. Int J Cancer 113:290–297PubMedGoogle Scholar
  92. Oremek GM, Kramer W, Seiffert UB, Jonas D (1997) Diagnostic value of skeletal AP and PSA with respect to skeletal scintigram in patients with prostatic disease. Anticancer Res 17:3035–3036PubMedGoogle Scholar
  93. Ornstein DK, Rayford W, Fusaro VA, Conrads TP, Ross SJ, Hitt BA, Wiggins WW, Veenstra TD, Liotta LA, Petricoin EF 3rd (2004) Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. J Urol 172: 1302–1305PubMedGoogle Scholar
  94. Parsons JK, Brawer MK, Cheli CD, Partin AW, Djavan R (2004) Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6–4.0 ng/mL range of total PSA. BJU Int 94:47–50PubMedGoogle Scholar
  95. Perlin E, Engeler JE Jr., Edson M, Karp D, McIntire KR, Waldmann TA serum in relation to specimen handling and storage conditions. Clin Chem Lab Med 38:1271–1275Google Scholar
  96. Khan MA, Partin AW (2004) Management of patients with an increasing prostate-specific antigen after radical prostatectomy. Curr Urol Rep 5:179–187PubMedGoogle Scholar
  97. Klezovitch O, Chevillet J, Mirosevich J, Roberts RL, Matusik RJ, Vasioukhin V (2004) Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 6:185–195PubMedGoogle Scholar
  98. Koistinen H, Paju A, Koistinen R, Finne P, Lovgren J, Wu P, Seppala M, Stenman UH (2002) Prostate-specific antigen and other prostatederived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3. Prostate 50:112–118PubMedGoogle Scholar
  99. Koshida K, Stigbrand T, Munck-Wikland E, Hisazumi H, Wahren B (1990) Analysis of serum placental alkaline phosphatase activity in testicular cancer and cigarette smokers. Urol Res 18:169–173PubMedGoogle Scholar
  100. Koshida K, Uchibayashi T, Yamamoto H, Hirano K (1996) Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma. Br J Urol 77:138–142PubMedGoogle Scholar
  101. Kovcin VN, Jelic SB, Ivanovic SM, Babovic NL (1997) Serum gonadotropin levels in patients with germ-cell tumors of the testis: interrelations, possible cross-reactions and interpretation of beta-HCG level. Int J Biol Markers 12:55–60PubMedGoogle Scholar
  102. Kuriyama M, Wang MC, Papsidero LD, Killian CS, Shimano T, Valenzuela L, Nishiura T, Murphy GP, Chu TM (1980) Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 40:4658–4662PubMedGoogle Scholar
  103. Lajer H, Daugaard G, Andersson AM, Skakkebaek NE (2002) Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancer. Int J Cancer 100:244–246PubMedGoogle Scholar
  104. Li MS, Li PF, Yang FY, He SP, Du GG, Li G (2002) The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells. Cell Res 12:151–156PubMedGoogle Scholar
  105. Lintula S, Vesalainen S, Rannikko A, Zhang WM, Finne P, Stenman J, Stenman UH (2004) Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction. Scand J Clin Lab Invest 64:93–100PubMedGoogle Scholar
  106. Lippert MC, Javadpour N (1981) Lactic dehydrogenase in the monitoring and prognosis of testicular cancer. Cancer 48:2274–2278PubMedGoogle Scholar
  107. Lippert M, Papadopoulos N, Javadpour N (1981) Role of lactate dehydrogenase isoenzymes in testicular cancer. Urology 18:50–53PubMedGoogle Scholar
  108. Liu T, Bauskin AR, Zaunders J, Brown DA, Pankhurst S, Russell PJ, Breit SN, Panhurst S (2003) Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res 63:5034–5040PubMedGoogle Scholar
  109. Manetti L, Lupi I, Genovesi M, Morselli L, Grasso L, Nencetti C, Gasperi M, Bogazzi F, Bartalena L, Martino E (2004) Serum prostate-specific antigen concentration is increased in acromegalic women. J Endocrinol Invest 27:643–647PubMedGoogle Scholar
  110. Mann K, Saller B (1994a) Tumours of the prostate gland. In: Klapdor R (ed) Tumour markers in clinical oncology: an overview. Sorin Biomedica, Turin, pp 145–150Google Scholar
  111. Mann K, Saller B (1994b) Tumours of the testis. In: Klapdor R (ed) Tumour markers in clinical oncology: an overview. Sorin Biomedica, Turin, pp 151–156Google Scholar
  112. Mann K, Schneider N, Hoermann R (1986) Thyrotropic activity of acidic isoelectric variants of human chorionic gonadotropin from trophoblastic tumors. Endocrinology 118: 1558–1566PubMedGoogle Scholar
  113. Masseyeff R, Bonet C, Drouet J, Sudaka P, Lalanne C (1974) Radioimmunoassay of alpha-fetoprotein. I. Technique and serum levels in the normal adult. Digestion 10:17–28PubMedGoogle Scholar
  114. Matsumura M, Bhatt AS, Andress D, Clegg N, Takayama TK, Craik CS, Nelson PS (2005) Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional scanning peptide libraries. Prostate 62:1–13PubMedGoogle Scholar
  115. Mazumdar M, Bajorin DF, Bacik J, Higgins G, Motzer RJ, Bosl GJ (2001) Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy. J Clin Oncol 19:2534–2541PubMedGoogle Scholar
  116. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, Oesterling JE (1995) Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 45:729–744PubMedGoogle Scholar
  117. Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP (1997) Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab 82:777–780PubMedGoogle Scholar
  118. Mikolajczyk SD, Catalona WJ, Evans CL, Linton HJ, Millar LS, Marker KM, Katir D, Amirkhan A, Rittenhouse HG (2004) Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer. Clin Chem 50:1017–1025PubMedGoogle Scholar
  119. Millan JL, Eriksson A, Stigbrand T (1982) A possible new locus of alkaline phosphatase expressed in human testis. Hum Genet 62:293–295PubMedGoogle Scholar
  120. Mohler JL, Siami PF, Flanigan RC (1987) False positive betahuman chorionic gonadotropin in testicular cancer. Urology 30:252–254PubMedGoogle Scholar
  121. Moller MB (1996) Association of testicular non-Hodgkin’s lymphomas with elevated serum levels of human chorionic gonadotropin-like material. Oncology 53:94–98PubMedGoogle Scholar
  122. Mora J, Gascon N, Tabernero JM, Germa JR, Gonzalez F (1995) Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseases. Eur J Cancer 31A:2239–2242PubMedGoogle Scholar
  123. Morote J, Lorente JA, Encabo G (1996) Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen. Cancer 78:2374–2378PubMedGoogle Scholar
  124. Morris MJ, Bosl GJ (2000) Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors. J Urol 163:796–801PubMedGoogle Scholar
  125. Nazeer T, Ro JY, Amato RJ, Park YW, Ordonez NG, Ayala AG (1998) Histologically pure seminoma with elevated alphafetoprotein: a clinicopathologic study of ten cases. Oncol Rep 5:1425–1429PubMedGoogle Scholar
  126. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr., Bruzek DJ, Rock RC, Brendler CB, Walsh PC (1988) Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139:766–772PubMedGoogle Scholar
  127. Olsson AY, Bjartell A, Lilja H, Lundwall A (2005) Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues. Int J Cancer 113:290–297PubMedGoogle Scholar
  128. Oremek GM, Kramer W, Seiffert UB, Jonas D (1997) Diagnostic value of skeletal AP and PSA with respect to skeletal scintigram in patients with prostatic disease. Anticancer Res 17:3035–3036PubMedGoogle Scholar
  129. Ornstein DK, Rayford W, Fusaro VA, Conrads TP, Ross SJ, Hitt BA, Wiggins WW, Veenstra TD, Liotta LA, Petricoin EF 3rd (2004) Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. J Urol 172:1302–1305PubMedGoogle Scholar
  130. Parsons JK, Brawer MK, Cheli CD, Partin AW, Djavan R (2004) Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA. BJU Int 94:47–50PubMedGoogle Scholar
  131. Perlin E, Engeler JE Jr., Edson M, Karp D, McIntire KR, Waldmann TA (1976) The value of serial measurement of both human chorionic gonadotropin and alpha-fetoprotein for monitoring germinal cell tumors. Cancer 37:215–219PubMedGoogle Scholar
  132. Peters MA, de Jong FH, Teerds KJ, de Rooij DG, Dieleman SJ, van Sluijs FJ (2000) Ageing, testicular tumours and the pituitary-testis axis in dogs. J Endocrinol 166:153–161PubMedGoogle Scholar
  133. Platz EA, De Marzo AM, Giovannucci E (2004) Prostate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA era. J Cell Biochem 91:553–557PubMedGoogle Scholar
  134. Reissigl A, Klocker H, Pointner J, Fink K, Horninger W, Ennemoser O, Strasser H, Colleselli K, Holtl L, Bartsch G (1996) Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening. Urology Suppl 48:62–66Google Scholar
  135. Riegman PH, Vlietstra RJ, van der Korput JA, Brinkmann AO, Trapman J (1991) The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol 5:1921–1930PubMedGoogle Scholar
  136. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW (1998) Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 35:275–368PubMedGoogle Scholar
  137. Ruoslahti E, Terry WD (1976) Alpha foetoprotein and serum albumin show sequence homology. Nature 260:804–805PubMedGoogle Scholar
  138. Saller B, Clara R, Spottl G, Siddle K, Mann K (1990) Testicular cancer secretes intact human choriogonadotropin (hCG) and its free betasubunit: evidence that hCG (+hCG-beta) assays are the most reliable in diagnosis and follow-up. Clin Chem 36:234–239PubMedGoogle Scholar
  139. Saraswathi A, Malati T (1994) Clinical relevance of alphafetoprotein microheterogeneity in alphafetoprotein-secreting tumors. Cancer Detect Prev 18:447–454PubMedGoogle Scholar
  140. Schefer H, Mattmann S, Joss RA (1998) Hereditary persistence of alpha-fetoprotein. Case report and review of the literature. Ann Oncol 9:667–672PubMedGoogle Scholar
  141. Seckl MJ, Rustin GJ, Bagshawe KD (1990) Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours. Br J Cancer 61:916–918PubMedGoogle Scholar
  142. Shulman MJ, Karam JA, Benaim EA (2004) Prostate-specific antigen doubling time predicts response to deferred antiandrogen therapy in men with androgen-independent prostate cancer. Urology 63:732–736PubMedGoogle Scholar
  143. Smith AA, Weng E, Handler M, Foreman NK (2004) Intracranial germ cell tumors: a single institution experience and review of the literature. J Neurooncol 68:153–159PubMedGoogle Scholar
  144. Smith JB (1970) Alpha-fetoprotein: occurrence in certain malignant diseases and review of clinical applications. Med Clin North Am 54:797–803PubMedGoogle Scholar
  145. Sokoll LJ, Bruzek DJ, Dua R, Dunn W, Mohr P, Wallerson G, Eisenberger M, Partin AW, Chan DW (2002) Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen. Urology 60:24–30PubMedGoogle Scholar
  146. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317:909–916PubMedGoogle Scholar
  147. Stephan C, Cammann H, Semjonow A, Diamandis EP, Wymenga LF, Lein M, Sinha P, Loening SA, Jung K (2002a) Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies. Clin Chem 48:1279–1287PubMedGoogle Scholar
  148. Stephan C, Jung K, Cammann H, Vogel B, Brux B, Kristiansen G, Rudolph B, Hauptmann S, Lein M, Schnorr D, Sinha P, Loening SA (2002b) An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis: results of a 5-year investigation. Int J Cancer 99:466–473PubMedGoogle Scholar
  149. Tahir SA, Ren C, Timme TL, Gdor Y, Hoogeveen R, Morrisett JD, Frolov A, Ayala G, Wheeler TM, Thompson TC (2003) Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer. Clin Cancer Res 9: 3653–3659PubMedGoogle Scholar
  150. Taketa K (1992) Alpha-fetoprotein in the 1990s. In: Sell S (ed) Serological cancer markers. Humana, Totowa, New Jersey, pp 31–46Google Scholar
  151. Talmadge K, Boorstein WR, Fiddes JC (1983) The human genome contains seven genes for the beta-subunit of chorionic gonadotropin but only one gene for the beta-subunit of luteinizing hormone. DNA 2:281–289PubMedGoogle Scholar
  152. Tatarinov IS, Afanas’eva AV, Parfenova LF (1963) On the development of the serum proteins in human ontogenesis. Vopr Med Khim 37:403–410Google Scholar
  153. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA Jr. (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level ? 4.0 ng per milliliter. N Engl J Med 350:2239–2246PubMedGoogle Scholar
  154. Tilghman SM, Belayew A (1982) Transcriptional control of the murine albumin/alpha-fetoprotein locus during development. Proc Natl Acad Sci USA 79:5254–5257PubMedGoogle Scholar
  155. Toppari J, Kaipia A, Kaleva M, Laato M, de Kretser DM, Krummen LA, Mather JP, Salmi TT (1998) Inhibin gene expression in a large cell calcifying Sertoli cell tumour and serum inhibin and activin levels. APMIS 106:101–112PubMedGoogle Scholar
  156. Tricoli JV, Schoenfeldt M, Conley BA (2004) Detection of prostate cancer and predicting progression: current and future diagnostic markers. Clin Cancer Res 10:3943–3953PubMedGoogle Scholar
  157. Trojan A, Joller-Jemelka H, Stahel RA, Jacky E, Hersberger M (2004) False-positive human serum chorionic gonadotropin in a patient with a history of germ cell cancer. Oncology 66:336–338PubMedGoogle Scholar
  158. Tucker DF, Oliver RT, Travers P, Bodmer WF (1985) Serum marker potential of placental alkaline phosphatase-like activity in testicular germ cell tumours evaluated by H17E2 monoclonal antibody assay. Br J Cancer 51:631–639PubMedGoogle Scholar
  159. Vessella RL, Santrach MA, Bronson D, Smith CJ, Klicka MJ, Lange PH (1984) Evaluation of AFP glycosylation heterogeneity in cancer patients with AFP-producing tumors. Int J Cancer 34:309–314PubMedGoogle Scholar
  160. von Eyben FE (1983) Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview. Oncodev Biol Med 4:395–414Google Scholar
  161. von Eyben FE, Skude G (1984) Lactate dehydrogenase and its isoenzyme, LDH-1, in serum are markers of testicular germ cell tumors. Clin Chem 30:340–341Google Scholar
  162. Wang MC, Valenzuela LA, Murphy GP, Chu TM (1979) Purification of a human prostate specific antigen. Invest Urol 17: 159–163PubMedGoogle Scholar
  163. Watanabe K, Saito A, Tamaoki T (1987) Cell-specific enhancer activity in a far upstream region of the human alpha-fetoprotein gene. J Biol Chem 262:4812–4818PubMedGoogle Scholar
  164. Waters WB (1999) Rational uses of PSA testing. In: AACC Proceedings. Tumor markers: successful laboratory practice for today and tomorrow.Google Scholar
  165. Witherspoon LR, Lapeyrolerie T (1997) Sensitive prostate specific antigen measurements identify men with long diseasefree intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy. J Urol 157:1322–1328PubMedGoogle Scholar
  166. Wolff JM, Ittel T, Borchers H, Brauers A, Jakse G (1998) Efficacy of skeletal alkaline phosphatase and prostate-specific antigen in the diagnosis of bone metastasis in cancer of the prostate. Urol Int 61:12–16PubMedGoogle Scholar
  167. Yamamoto R, Ohkouchi T, Wakui Y, Minobe S, Watari H, Shimizu K, Satomura S, Sakuragi N (2003) A study on the micro heterogeneity of alpha-fetoproteins produced by yolk sac and germ cell tumors. Acta Obstet Gynecol Scand 82:876–882PubMedGoogle Scholar
  168. Yuan JJ, Coplen DE, Petros JA, Figenshau RS, Ratliff TL, Smith DS, Catalona WJ (1992) Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. J Urol 147:810–814PubMedGoogle Scholar
  169. Yuasa T, Yoshiki T, Ogawa O, Tanaka T, Isono T, Mishina M, Higuchi K, Okada Y, Yoshida O (1999) Detection of alpha-fetoprotein mRNA in seminoma. J Androl 20:336–340PubMedGoogle Scholar
  170. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Munstedt K, Rao CV, Lang U, Preissner KT (2002) Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 87:5290–5296PubMedGoogle Scholar

Bibliografia

  1. Ahn HS, Lee SW, Yoon SJ, Hann HJ, Hong JM (2004) A comparison of colour duplex sonography after transurethral alprostadil and intracavernous alprostadil in the assessment of erectile dysfunction. J Int Med Res 32:317–323PubMedGoogle Scholar
  2. Aizenstein RI, DiDomenico D, Wilbur AC, O’Neil HK (1998) Testicular microlithiasis: association with male infertility. J Clin Ultrasound 26:195–198PubMedGoogle Scholar
  3. Carmignani L, Gadda F, Mancini M et al (2004) Detection of ultrasonographic lesions in severe male infertility. J Urol 172:1045–1047PubMedGoogle Scholar
  4. Cornud F, Belin X, Delafontaine D, Amar T, Hélénon O, Moreau JF (1997) Imaging of obstructive azoospermia. Eur Radiol 7:1079–1085PubMedGoogle Scholar
  5. De Santis M, Becherer A, Bokemeyer C et al (2004) 2-18Fluorodeoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol 22:1034–1039PubMedGoogle Scholar
  6. Fornara P, Gerbershagen HP (2004) Ultrasound in patients affected with Peyronie’s disease.World J Urol 22:365–367PubMedGoogle Scholar
  7. Hain SF, Maisey MN (2003) Positron emission tomography for urological tumours. BJU Int 92:159–164PubMedGoogle Scholar
  8. Har-Toov J, Eytan O, Hauser R, Yavetz H, Elad D, Jaffa AJ (2004) A new power doppler ultrasound guiding technique for improved testicular sperm extraction. Fertil Steril 81:430–434PubMedGoogle Scholar
  9. Herwig R, Tosun K, Pinggera GM et al (2004) Tissue perfusion essential for spermatogenesis and outcome of testicular sperm extraction (TESE) for assisted reproduction. J Assist Reprod Genet 21:175–180PubMedGoogle Scholar
  10. Jones TR, Zagoria RJ, Jarow JP (1997) Transrectal US-guided seminal vesiculography. Radiology 205:276–278PubMedGoogle Scholar
  11. Kuligowska E, Fenlon HM (1998) Transrectal US in male infertility: spectrum of findings and role in patient care. Radiology 207:173–181PubMedGoogle Scholar
  12. Lenz S, Thomsen JK, Giwercman A, Hertel NT, Herts J, Skakkebaek NE (1994) Ultrasonic texture and volume of testicles in infertile men. Hum Reprod 9:878–881PubMedGoogle Scholar
  13. Lont AP, Besnard APE, Gallee MPW, Van Tinteren H, Horenblas S (2003) A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int 91:493–495PubMedGoogle Scholar
  14. Miller RL, Wissman R, White S, Ragosin R (1996) Testicular microlithiasis: a benign condition with a malignant association. J Clin Ultrasound 24:197–202PubMedGoogle Scholar
  15. Oyen R, Verbist B, Verswijvel G (1999) Imaging of testicular neoplasms. In: Petrovich Z, Baert L, Brady LW (eds) Carcinoma of the kidney and testis, and rare urologic malignancies. Springer, Berlin Heidelberg New YorkGoogle Scholar
  16. Oyen RH (2002) Scrotal ultrasound. Eur Radiol 12:19–34PubMedGoogle Scholar
  17. Pavlica P, Barozzi L (2001) Imaging of the acute scrotum. Eur Radiol 11:220–228PubMedGoogle Scholar
  18. Pierik FH, Dohle GR, van Muiswinkel JM, Vreeburg JT, Weber RF (1999) Is routine scrotal ultrasound advantageous in infertile men? J Urol 162:1618–1620PubMedGoogle Scholar
  19. Pretorius ES, Siegelman ES, Ramchandani P, Banner MP (2001) MR imaging of the penis. Radiographics 21:S283–S298PubMedGoogle Scholar
  20. Rhoden EL, Estrada C, Levine L, Morgentaler A (2003) The value of pituitary magnetic resonance imaging in men with hypogonadism. J Urol 170:795–798PubMedGoogle Scholar
  21. Sakamoto H, Shimada M, Yoshida H (2002) Hemodynamic evaluation of the penile arterial system in patients with erectile dysfunction using power Doppler imaging. Urology 60:480–484PubMedGoogle Scholar
  22. Scardino E, Villa G, Bonomo G et al (2004) Magnetic resonance imaging combined with artificial erection for local staging disease. World J Urol 22:365–367 of penile cancer. Urology 63:1158-1162Google Scholar
  23. Schiff JD, Li PS, Goldstein M (2004) Correlation of ultrasonographic and orchidometer measurements of testis volume in adults. BJU Int 93:1015–1017PubMedGoogle Scholar
  24. Shvarts O, Han K, Seltzer M, Pantuck AJ, Belldegrun AS (2002) Positron emission tomography in urologic oncology. Cancer Control 9:335–342PubMedGoogle Scholar
  25. Spermon JR, De Geus-Oei LF, Kiemeney LALM, Witjes JA, Oyen WJG (2002) The role of 18fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours. BJU Int 89:549–556PubMedGoogle Scholar
  26. Thomas AJ (2004) Should testicular ultrasound be considered a medically necessary test for the spermatogenically impaired male? J Urol 172:829–830PubMedGoogle Scholar
  27. Thomas K, Wood SJ, Thompson AJM, Pilling D, Lewis-Jones DI (2000) The incidence and significance of testicular microlithiasis in a subfertile population. Br J Radiol 73:494–497PubMedGoogle Scholar
  28. Wilkins CJ, Sriprasad S, Sidhu P (2003) Colour doppler ultrasound of the penis. Radiology 58:514–523Google Scholar
  29. Woodward PJ, Sohaey R, O’Donoghue MJ, Green DE (2002) From the archives of the AFIP Tumors and tumorlike lesions of the testis: radiologic-pathologic correlation. Radiographics 22:189–216PubMedGoogle Scholar

Bibliografia

  1. Chakraborty J, Hikim AP, Jhunjhunwala JS (1985) Stagnation of blood in the microcirculatory vessels in the testes of men with varicocele. J Androl 6:117–126PubMedGoogle Scholar
  2. Chiou KR, Anderson JC, Wobig RK, Rosinsky DE, Matamoros A, Chen WS, Taylor RJ (1997) Color Doppler ultrasound criteria to diagnose varicoceles: correlation of a new scoring system with physical examination. Urology 50:953–956PubMedGoogle Scholar
  3. Comhaire F, Monteyne R, Kunnen M (1976) The value of scrotal thermography as compared with selective retrograde venography of the internal spermatic vein for the diagnosis of subclinical varicocele. Fertil Steril 27:694–698PubMedGoogle Scholar
  4. Comhaire F, Kunnen M, Nahum C (1981) Radiological anatomy of the internal spermatic veins in 200 retrograde venograms. Int J Androl 4:379–387PubMedGoogle Scholar
  5. Cozzolino DJ, Lipshultz LI (2001) Varicocele as a progressive lesion: positive effect of varicocele repair. Hum Reprod Update 7:55–58PubMedGoogle Scholar
  6. Eskew A, Watson N, Wolfman R, Bechtold R, Scharling E, Jarow J (1993) The accuracy of ultrasonographic diagnosis of varicoceles. Fertil Steril 60:693–697PubMedGoogle Scholar
  7. Evers J, Collins A (2003) Assessment of efficacy of varicocele repair for male subfertility: a systematic review. Lancet 361: 1849–1852PubMedGoogle Scholar
  8. Evers JL, Collins JA (2004) Surgery or embolization for varicocele in subfertile men. Cochrane Database Syst Rev: CD000479Google Scholar
  9. Ganong WF (1999) Medical physiology, 19th edn. Lange Medical Books/McGraw-Hill, New York, pp 550–567Google Scholar
  10. Gat Y, Zukerman Z, Bachar GN, Feldberg DO, Gornish M (2003) Adolescent varicocele: is it a unilateral disease? Urology 62:742–746; Editorial comment p 746; Reply by authors pp 746–747PubMedGoogle Scholar
  11. Gat Y, Bachar GN, Zukerman Z, Belenky A, Gornish M (2004a) Varicocele: a bilateral disease. Fertil Steril 81:424–429; Editorial comments in J Urol 2004; 172:790–791PubMedGoogle Scholar
  12. Gat Y, Bachar GN, Zuckerman Z, Belenky A, Gornish M (2004b) Physical examination may miss the diagnosis of bilateral varicocele: a comparative study of 4 diagnostic modalities. J Urol 172 (4 Pt 1):141–1417; Editorial commentary and authors’ reply in J Urol 2005; 173:2208–2209Google Scholar
  13. Gat Y, Gornish M, Belenky A, Bachar GN (2004c) Elevation of serum testosterone and free testosterone after embolization of the internal spermatic vein for the treatment of varicocele in infertile men. Hum Reprod 19:2303–2306; Editorial comments in J Urol 2005; 173:2079PubMedGoogle Scholar
  14. Gat Y, Bachar GN, Everaert K, Levinger U, Gornish M (2005a) Induction of spermatogenesis in azoospermic men after internal spermatic veins embolization for the treatment of varicocele. Hum Reprod 20:1013–1017PubMedGoogle Scholar
  15. Gat Y, Chakraborty J, Zukerman Z, Gornish M (2005b) Varicocele, hypoxia, and male infertility. Fluid mechanics analysis of the impaired testicular venous drainage system. Hum Reprod 20:2614–2619PubMedGoogle Scholar
  16. Goldstein M, Eid JF (1989) Elevation of intratesticular and scrotal skin surface temperature in men with varicocele. J Urol 142:743–745PubMedGoogle Scholar
  17. Hamm B, Fobbe F, Sorensen R, Felsenberg D (1986) Varicoceles: combined sonography and thermography in diagnosis and posttherapeutic evaluation. Radiology 160:419PubMedGoogle Scholar
  18. Hoekstra T, Witt MA (1995) The correlation of internal spermatic vein palpability with ultrasonographic diameter and reversal of venous flow. J Urol 153:82–84PubMedGoogle Scholar
  19. Kunnen M, Comhaire F (1992) Nonsurgical cure of the varicocele by transcatheter embolization of the internal spermatic veins with tissue adhesive (histoacryl transparent). In: Castaneda-Zuniga WR, Tadavarthy SM (eds) Interventional radiology, 2nd edn, part 2. Williams and Wilkinson, Baltimore, Md., pp 73–100Google Scholar
  20. Matthews GJ, Matthews ED, Goldstein M (1998) Induction of spermatogenesis and achievement of pregnancy after microsurgical varicolectomy in men with azoospermia and severe oligoasthenospermia. Fertil Steril 70:71–75PubMedGoogle Scholar
  21. McClure DR, Hricak H (1986) Scrotal ultrasound in infertile man: detection of subclinical unilateral and bilateral varicoceles. J Urol 135:711–715PubMedGoogle Scholar
  22. Nagler HM (2004) Varicocele. Where, why and, if so, how? J Urol 172 (4Pt1): 1239–1240PubMedGoogle Scholar
  23. Netto NR, Lemos GC, Barbosa EM (1984) The value of thermography and of the Doppler ultrasound in varicocele diagnosis. Int J Fertil 29:176–179Google Scholar
  24. Pasqualotto FF, Lucon AM, Hallak J, Goes PM, Saldanha LB, Arap S (2003) Induction of spermatogenesis in azoospermic men after varicocele repair. Hum Reprod 18:108–112PubMedGoogle Scholar
  25. Petros JA, Andriola GL, Middletoon WD, Picus DA (1991) Correlation of testicular color Doppler ultrasonography, physical examination and venography in the detection of left varicocele in men with infertility. J Urol 145:785–788PubMedGoogle Scholar
  26. Pochaczevsky R, Lee WJ, Mallett E (1986) Management of male infertility: roles of contact thermography, spermatic venography, and embolization. AJR 147:97PubMedGoogle Scholar
  27. Streeter VL (1971) Fluid mechanics, 5th edn. McGraw-Hill, New York, p 77Google Scholar
  28. Trum JW, Gubler FM, Laan RL, Van der Veen F (1996) The value of palpation, varicoscreen contact thermography and colour Doppler ultrasound in the diagnosis of varicocele. Hum Reprod 11:1232–1235PubMedGoogle Scholar

Bibliografia

  1. Beckstead JH (1983) Alkaline phosphatase histochemistry in human germ cell neoplasms. Am J Surg Pathol 7:341–349PubMedGoogle Scholar
  2. Bergmann M, Kliesch S (1998) Hodenbiopsie. In: Krause W, Weidner W (eds) Andrologie. Enke, Stuttgart, pp 66–71Google Scholar
  3. Bergmann M, Behre HM, Nieschlag E (1994) Serum FSH and testicular morphology in male infertility. Clin Endocrinol 40:133–136Google Scholar
  4. Bruning G, Dierichs R, Stümpel C, Bergmann M (1993) Sertoli cell nuclear changes in human testicular biopsies as revealed by three dimensional reconstruction. Andrologia 25:311–316PubMedGoogle Scholar
  5. Craft I, Tsirigotis M, Courtald E, Farrer-Brown G (1997) Testicular needle aspiration as an alternative to biopsy for the assessment of spermatogenesis. Hum Reprod 10:1483–1487Google Scholar
  6. Dieckmann KP, Huland H (2001) Hodentumoren. In: Hautmann RE, Huland H (eds) Andrologie. Springer, Berlin Heidelberg New York, pp 223–236Google Scholar
  7. Holstein AF, Eckmann C (1986) Megalospermatocytes: indicators of disturbed meiosis in man. Andrologia 18:601–609PubMedGoogle Scholar
  8. Holstein AF, Schirren C, Roosen-Runge EC (1988) Illustrated pathology of human spermatogenesis. Grosse, BerlinGoogle Scholar
  9. Jezek D, Knuth UA, Schulze W (1998) Successful testicular sperm extraction (TESE) in spite of high serum follicle stimulating hormone and azoospermia: correlation between testicular morphology, TESE results, semen analysis and serum hormone values in 103 infertile men. Hum Reprod 13:1230–1234PubMedGoogle Scholar
  10. Johannisson R, Schulze W, Holstein AF (2003) Megalospermatocytes in the human testis exhibit asynapsis of chromosomes. Andrologia 35:146–151PubMedGoogle Scholar
  11. Johnson SG (1970) Testicular biopsy score count — a method for registration of spermatogenesis in human testis: normal values and results in 335 hypogonadal males. Hormone 1:2Google Scholar
  12. Kliesch S, Thomaidis T, Schütte B, Pühse G, Kater B, Roth S, Bergmann M (2003) Update on the diagnostic safety for detection of testicular intraepithelial neoplasia (TIN). APMIS 111:70–75PubMedGoogle Scholar
  13. Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E (2004) Klinefelter’s syndrome. Lancet 364:273–284PubMedGoogle Scholar
  14. Lewin A, Reubinoff B, Porat-Kratz A (1999) Testicular needle aspiration: the alternative method for sperm retrieval in non-obstructive azoospermia. Hum Reprod 14:1785–1790PubMedGoogle Scholar
  15. Regadera J, Martinez-Garcia F, Gonzalez-Peramato P, Serrano A, Nistal M, Suarez-Quian C (2001) Androgen receptor expression in Sertoli cells as a function of seminiferous tubule maturation in the human cryptorchid testis. J Clin Endocrinol Metab 86:431–421Google Scholar
  16. Rørth M, Raijpert-De Meyts E, Andersson L, Diekmann K-P, Fossa SD, Grigor KM, Hendry WF, Herr HW, Looijenga LH, Oosterhuis JW, Skakkebaek NE (2000) Carcinoma in situ of the testis. Scand J Urol Nephrol Suppl 205:166–186PubMedGoogle Scholar
  17. Sharpe RM, McKinnell C, Kivlin C, Fisher S (2003) Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 125:769–784PubMedGoogle Scholar
  18. Shufaro Y, Prus D, Laufer N, Simon A (2002) Impact of repeated testicular fine needle aspirations (TEFNA) and testicular sperm extraction (TESE) on the microscopic morphology of the testis: an animal model. Hum Reprod 17:1795–1799PubMedGoogle Scholar
  19. Sigg C (1979) Klassifizierung tubulärer Hodenatrophien bei Sterilitätsabklärungen. Bedeutung der sogenannten bunten Atrophie. Schweiz Med Wschr 109:1284–1293PubMedGoogle Scholar
  20. Silber SJ, Van Steirteghem AC, Liu J, Nagy Z, Tournaye H, Devreoey P (1995) High fertilization and pregnancy rate after intracytoplasmic sperm injection with spermatozoa obtained from testicular biopsy. Hum Reprod 10:148–152PubMedGoogle Scholar
  21. Steger K, Rey R, Kliesch S, Louis F, Schleicher G, Bergmann M (1996) Immunohistochemical detection of immature Sertoli cell markers in testicular tissue of infertile adult men: a preliminary study. Int J Androl 19:122–128PubMedGoogle Scholar
  22. Steger K, Aleithe I, Behre H-M, Bergmann M (1998) The proliferation of spermatogonia in normal and pathologic human seminiferous epithelium: an immunohistochemical study using monoclonal antibodies against Ki-67 protein and proliferating cell nuclear antigen PCNA). Mol Hum Reprod 4: 227–233PubMedGoogle Scholar
  23. Steger K, Failing K, Klonisch T, Behre HM, Manning M, Weidner W, Hertle L, Bergmann M, Kliesch S (2001) Round spermatids from infertile men exhibit decreased levels of protamine-1 and protamine 2 mRNA. Hum Reprod 16:709–716PubMedGoogle Scholar
  24. Steger K, Fink L, Failing K, Bohle RM, Kliesch S, Weidner W, Bergmann M (2003) Decreased protamine-1 transcript levels in testes from infertile men. Mol Hum Reprod 9:331–336PubMedGoogle Scholar
  25. von Eckardstein S, Tsakmakidis G, Kamischke A, Rolf C, Nieschlag E (2001) Sonographic testicular microlithiasis as an indicator of premalignant conditions in normal and infertile men. J Androl 22:818–824Google Scholar
  26. Weidner W, Colpi GM, Hargreave TB, Papp GK, Pomerol JM, The EAU Working Group on Male Infertility (2002) EAU guidelines on male infertility. Eur Urol 42:313–322PubMedGoogle Scholar

Bibliografia

  1. Augarten A, Yahav Y, Kerem BS, Halle D, Laufer J, Szeinberg A, Dor J et al (1994) Congenital bilateral absence of the vas deferens in the absence of cystic fibrosis. Lancet 344:1473–1474PubMedGoogle Scholar
  2. Bjelland S, Seeberg E (2003) Mutagenicity, toxicity and repair of DNA base damage induced by oxidation. Mutat Res 531:37–80PubMedGoogle Scholar
  3. Bogatcheva NV, Agoulnik AI (2005) INSL3/LGR8 role in testicular descent and cryptorchidism. Reprod Biomed Online 10:49–54PubMedGoogle Scholar
  4. Bonduelle M, Liebaers I, Deketelaere V, Derde MP, Camus M, Devroey P, Van Steirteghem A (2002) Neonatal data on a cohort of 2889 infants born after ICSI (1991–1999) and of 2995 infants born after IVF (1983–1999). Hum Reprod 17:671–94PubMedGoogle Scholar
  5. British Andrology Society (1999) British Andrology Society guidelines for the screening of semen donors for donor insemination. Hum Reprod 14:1823–1826PubMedGoogle Scholar
  6. Brown GM, Furlong RA, Sargent CA, Erickson RP, Longepied G, Mitchaeli M et al (1998) Characterisation of the coding sequence and fine mapping of the human DFFRY gene and comparative expression analysis and mapping to the Sxrbinterval of the mouse Y chromosome of the Dffry gene. Hum Mol Genet 7:97–107PubMedGoogle Scholar
  7. Caceres C, Ribes E, Muller S, Cornudella L, Chiva M (1994) Characterization of chromatin-condensing proteins during spermatogenesis in a neogastropod mollusc (Murex branda ris). Mol Reprod Dev 38:440–452PubMedGoogle Scholar
  8. Chandley AC, Edmond PE, Christie S, Gowans I, Fletcher J, Frackiewicz A, Newton M (1975) Cytogenetics and infertility in man. Results of a five year study of men attending a subfertility clinic. Ann Hum Genet 39:231–254PubMedGoogle Scholar
  9. Chandley AC, Ambros P, McBeath S, Hargreave TB, Kilanowski F, Spowart G (1986) Short arm dicentric Y chromosome with associated structural defects in a sterile man. Hum Genet 73:350–353PubMedGoogle Scholar
  10. Chevret E, Rousseaux S, Monteil M (1996) Increased incidence of hyperhaploid 24 XY spermatozoa detected by three-colour FISH in a 46XY/47XXY male. Hum Genet 97:171–175PubMedGoogle Scholar
  11. Chevret ERS, Monteil M, Usson Y, Cozzi J, Pelletier R, Sele B (1997) Meiotic behaviour of sex chromosomes investigated by three-colour FISH on 35142 sperm nuclei from two 47,XYY males. Hum Genet 99:407–412PubMedGoogle Scholar
  12. Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey MC et al (1995) Mutations in cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 332:1475–1480PubMedGoogle Scholar
  13. Chu CS, Trapnell BC, Curristin S, Cutting GR, Crystal RG (1993) Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 3:151–156PubMedGoogle Scholar
  14. Cooke HJ, Lee M, Kerr S, Ruggiu M (1996) A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. Hum Mol Genet 5:513–516PubMedGoogle Scholar
  15. Cozzi J, Chevret E, Rousseaux S (1994) Achievement of meiosis in XXY germ cells: study of 543 sperm karyotypes from an XY/XXY mosaic patient. Hum Genet 93:32–34PubMedGoogle Scholar
  16. Danan C, Sterberg D, Steirteghem AV, Cazeneuve C, Duquesnoy P, Besmond C et al (1999) Evaluation of parental mitochondrial inheritance in neonates born after intracytoplasmic sperm injection. Am J Hum Genet 65:463–473PubMedGoogle Scholar
  17. De Braekeleer M, Dao TN (1991) Cytogenetic studies in male infertility: a review. Hum Reprod 6:245–250PubMedGoogle Scholar
  18. De Braekeleer M, Ferec C (1996) Mutations in the cystic fibrosis gene in men with congenital bilateral absence of the vas deferens. Mol Hum Reprod 2:669–677PubMedGoogle Scholar
  19. Dean M, Santis G (1994) Heterogenicity in the severity of cystic fibrosis and the role of the CFTR gene mutations. Hum Genet 93:364–368PubMedGoogle Scholar
  20. DeBaun MR, Niemitz EL, Feinberg AP (2003) Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet 72:156–160PubMedGoogle Scholar
  21. Delbridge ML, Harry JL, Toder R, Waugh O’Neill RJ, Kun Ma, Chandley AC, Marshall Graves JA (1997) A human candidate spermatogenesis gene, RBMI, is conserved and amplified on the marsupial Y chromosome. Nature Genet 15:131–136PubMedGoogle Scholar
  22. Delbridge ML, Ma K, Subbarao MN, Cooke HJ, Bhasin S, Graves JAM (1998) Evolution of mammalian HNRPG and its relationship with the putative azoospermia factor RBM. Mammalian Genome 9:168–170PubMedGoogle Scholar
  23. Delbridge ML, Lingenfelter PA, Disteche CM, Graves JA (1999) The candidate spermatogenesis gene RBMY has a homologue on the human X chromosome. Nat Genet 22:223–224PubMedGoogle Scholar
  24. Donat R, McNeill AS, Fitzpatrick DR, Hargreave TB (1997) The incidence of cystic fibrosis gene mutation in patients with congenital bilateral absence of the vas deferens in Scotland. Br J Urol 79:74–77PubMedGoogle Scholar
  25. Dorfman DM, Genest DR, Reijo-Pera RA (1999) Human DAZL1 encodes candidate fertility factor in women that localizes to the prenatal and postnatal germ cells. Hum Reprod 14:2531–2536PubMedGoogle Scholar
  26. Drake MJ, Quinn FM (1996) Absent vas deferens and ipsilateral multicystic dysplastic kidney in a child. Br J Urol 77:756–757PubMedGoogle Scholar
  27. Elliot DJ, Oghene K, Makarova O, Hargreave TB, Chandley AC, Eperon IC, Cooke HJ (1998) Dynamic changes in the subnuclear organisation of pre-mRNA splicing proteins and RBM during human germ cell development. J Cell Sci 111:1255–1265Google Scholar
  28. Elliott DJ, Venables JP, Newton CS, Lawson D, Boyle S, Eperon IC, Cooke HJ (2000) An evolutionarily conserved germ cellspecific hnRNP is encoded by a retrotransposed gene. Hum Mol Genet 9:2117–2124PubMedGoogle Scholar
  29. Estop AM, Munne S, Cieply KM, Vandermark KK, Lamb AN, Fisch H (1998) Meiotic products of a Klinefelter 47,XXY male as determined by sperm fluorescence in-situ hybridization analysis. Hum Reprod 13:124–127PubMedGoogle Scholar
  30. Ferlin A, Moro E, Onisto M, Toscano E, Brettelia A, Foresta C (1999) Absence of testicular DAZ gene expression in idiopathic severe testiculopathies. Hum Reprod 14:2286–2292PubMedGoogle Scholar
  31. Fernandes S, Paracchini S, Meyer LH, Floridia G, Tyler M, Smith C, Vogt PH (2004) A large AZFc deletion removes and nearby genes from men in Y haplogroup N. Am J Hum Genet 74:180–187PubMedGoogle Scholar
  32. Fiddler M, Pergament E (1996) Germline gene therapy: its time is near. Mol Hum Reprod 2:75–76PubMedGoogle Scholar
  33. Finkelstein S, Mukamel E, Yavetz H, Paz G, Avivi L (1998) Increased rate of nondisjunction in sex cells derived from low quality semen. Hum Genet 102:129–137PubMedGoogle Scholar
  34. Foresta C, Rassato M, Garolla A et al (1996) Male infertility and ICSI: are there any limits? Hum Reprod 11:2347–2348PubMedGoogle Scholar
  35. Foresta C, Ferlin A, Garolla A et al (1997) Y-Chromosome deletions in idiopathic severe testiculopathies. J Clin Endocrinol Metab 82:1075–1080PubMedGoogle Scholar
  36. Foresta C, Galeazzi C, Bettella A, Stella M, Scandellari C (1998) High incidence of sperm sex chromosomes aneuploidies in two patients with Klinefelter’s syndrome. J Clin Endocrinol Metab 83:203–205PubMedGoogle Scholar
  37. Foresta C, Galeazzi C, Bettella A, Marin P, Rossato M, Garolla A, Ferlin A (1999) Analysis of meiosis in intratesticular germ cells from subjects affected by classic Klinefelter’s syndrome. J Clin Endocrinol Metab 84:3807–3810PubMedGoogle Scholar
  38. Foresta C, Ferlin A, Moro E (2000) Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility. Hum Mol Genet 9:1161–1169PubMedGoogle Scholar
  39. Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, Carrozzo R et al (1991) A gene deleted in Kallmann’s syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353:529–536PubMedGoogle Scholar
  40. Gabriel-Robez O, Rumpler Y, Ratomponirina C, Petit C, Levilliers J, Croquette MF, Couturier J (1990) Deletion of the pseudoautosomal region and lack of sex chromosome pairing at pachytene in two infertile men carrying an X-Y translocation. Cytogenet Cell Genet 54:38–42PubMedGoogle Scholar
  41. Gazvani MR, Wilson EDA, Richmond DH, Howard PJ, Kingsland CR, Lewis-Jones DI (2000) Evaluation of the role of mitotic instability in karyotypically normal men with oligozoospermia. Fertil Steril 73:51–55PubMedGoogle Scholar
  42. Girardi SK, Mielnik A, Schlegel PN (1997) Submicroscopic deletions in the Y chromosome of infertile men. Hum Reprod 12:1635–1641PubMedGoogle Scholar
  43. Gonialves J, McElreavey K, Carreiro H, Vale F, Marques R, Simao L et al (1996) An azoospermic man with a submicroscopic interstitial deletion on the Xp pseudoautosomal region [abstract]. In: Human Reproduction, Vol 11, Abstract book, 1 June 1996, 12th Annual Meeting, Maastricht, 30 June to 3 July 1996. European Society of Human Reproduction and Embryology, ISSN 0268–1161 Coden HUREEE, Oxford University PressGoogle Scholar
  44. Guttenbach M, Michelmann HW, Hinney B, Engel W, Schmid M (1997) Segregation of sex chromosomes into sperm nuclei in a man with 47,XXY Klinefelter’s karyotype: a FISHanalysis. Hum Genet 99:474–477PubMedGoogle Scholar
  45. Hackstein JH Hochstenbach R Pearson PL (2000) Towards an understanding of the genetics of human male infertility: lessons from flies. Trends Genet 16:565–572PubMedGoogle Scholar
  46. Hefferon TW, Groman JD, Yurk CE, Cutting GR (2004) A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing. Proc Natl Acad Sci USA 101:3504–3509PubMedGoogle Scholar
  47. Henegariu O, Hirschmann P, Killian K, Kirsch S, Lengauer C, Maiwald R et al (1994) Rapid screening of the Y chromosome in idiopathic sterile men, diagnostic for deletions in AZF, a genetic Y factor expressed during spermatogenesis. Andrologia 26:97–106PubMedGoogle Scholar
  48. Henkel NDI, Hajimohammad M, Stalf T, Hoogendijk C, Mehnert C, Menkveld R, Gips H, Schill WB, Kruger TF (2004) Influence of deoxyribonucleic acid damage on fertilization and pregnancy. Fertil Steril 81:965–972PubMedGoogle Scholar
  49. Hennebicq S, Pelletier R, Rousseaux S, Sele B (1999) Segregation of sex chromosomes in a Klinefelter patient (47,XXY) [abstract]. In: Human Reproduction, Vol 14, Abstract book, 1 June 1999, 15th Annual Meeting, Tours, 26-30 June 1999. European Society ofHuman Reproduction and Embryology, ISSN 0268–1161 Coden HUREEE, Oxford University PressGoogle Scholar
  50. Hennebicq S, Pelletier R, Bergues U, Rousseaux S (2001) Risk of trisomy 21 in offspring of patients with Klinefelter’s syndrome. Lancet 357:2104–2105PubMedGoogle Scholar
  51. Hopps CV, Mielnik A, Goldstein M, Palermo GD, Rosenwaks Z, Schlegel PN (2003) Detection of sperm in men with Y chromosome microdeletions of the AZFa, AZFb and AZFc regions. Hum Reprod 18:1660–1665PubMedGoogle Scholar
  52. Horn N, Tonnesen T, Tumer Z (1992) Menkes disease:an Xlinked neurological disorder of copper metabolism. Brain Pathol 2:351–362PubMedGoogle Scholar
  53. Hunt PA, Hassold TJ (2002) Sex matters in meiosis. Science 296:2181–2183PubMedGoogle Scholar
  54. Irvine DS, Twigg JP, Gordon EL, Fulton N, Milne PA, Aitken RJ (2000) DNA integrity in human spermatozoa: relationships with semen quality. J Androl 21:33–44PubMedGoogle Scholar
  55. Jensen M, Leffers H, Petersen JH, Nyboe Andersen A, Jorgensen N, Carlsen E, Jensen TK, Skakkebaek NE, Rajpert-De Meyts E (2004) Frequent polymorphism of the mitochondrial DNA polymerase gamma gene (POLG) in patients with normal spermiograms and unexplained subfertility. Hum Reprod 19:65–70PubMedGoogle Scholar
  56. Johnson MD (1998) Genetic risks of intracytoplasmic sperm injection in the treatment of male infertility: recommendations for genetic counseling and screening. Fertil Steril 70:397–411PubMedGoogle Scholar
  57. Kahraman S, Findikli N, Berkil H, Bakircioglu E, Donmez E, Sertyel S, Biricik A (2003) Results of preimplantation genetic diagnosis in patients with Klinefelter’s syndrome. Reprod Biomed Online 7:346–352PubMedGoogle Scholar
  58. Kamischke A, Gromoll J, Simoni M, Behre HM, Nieschlag E (1999) Transmission of a Y chromosomal deletion involving the deleted in azoospermia (DAZ) and chromodomain (CDYI) genes from father to son through intracytoplasmic sperm injection. Hum Reprod 14:2320–2322PubMedGoogle Scholar
  59. Kent-First MG, Kol S, Maullem A, Blazer S, Itskovitz-Eldor J (1996) Infertility in intracytoplasmic sperm injectionderived sons. Lancet 348:332PubMedGoogle Scholar
  60. Kent-First M, Muallem A, Shultz J Pryor J, Roberts K, Nolten W, Meisner L, Chandley A, Gouchy G, Jorgensen L, Havighurst T, Grosch J (1999) Defining regions of the Y-chromosome responsible formale infertility and identification of a fourth AZF region (AZFD) by Ychromosome microdeletion detection. Mol Reprod Dev 53:27–41PubMedGoogle Scholar
  61. Kleiman SE, Yogev L, Gamzu R, Hauser R, Botchan A, Lessing JB et al (1999) Genetic evaluation of infertile men. Hum Reprod 14:33–38PubMedGoogle Scholar
  62. Kobayashi K, Mizuno K, Hida A et al (1994) PCR analysis of the Y chromosome long arm in azoospermic patients — evidence for a second locus required for spermatogenesis. Hum Mol Genet 3:1965–1967PubMedGoogle Scholar
  63. Komori S, Horiuchi I, Hamada Y, Hasegawa A, Kasumi H, Kondoh N, Sawai H, Toji H, Shigeta M, Shima H, Koyama K (2004) Birth of healthy neonates after intracytoplasmic injection of ejaculated or testicular spermatozoa from men with nonmosaic Klinefelter’s syndrome: a report of 2 cases. J Reprod Med 49:126–130PubMedGoogle Scholar
  64. Krausz C, Bussani-Mastellone C, Granchi S, McElreavey K, Scarselli G, Forti G (1999) Screening for microdeletions of Y chromosome genes in patients undergoing intracytoplasmic sperm injection. Hum Reprod 14:1717–1721PubMedGoogle Scholar
  65. Kupker W, Ludwig M, Hahn K et al (1996) Prevalence of microdeletions in the azoospermia factor region of the Y chromosome in cases of azoospermia and severe oligoasthenoteratozoospermia. 12th Annual Meeting of the EHSRE, Maastricht 1996. Hum Reprod 11:57Google Scholar
  66. Kuroki Y, Iwamoto T, Lee J, Yoshiike M, Nozawa S, Nishida T et al (1999) Spermatogenic ability is different among males in different Y chromosome lineage. Hum Genet 44:289–292Google Scholar
  67. Lahn BT, Tang ZL, Zhou J, Barndt RJ, Parvinen M, Allis CD, Page DC (2003) Previously uncharacterized histone acetyltransferases implicated in mammalian spermatogenesis. EMBO Rep 4:877–82 [Epub 2003 August 08. Related Articles, Links Cdyl: a new transcriptional co-repressor. Proc Natl Acad Sci USA 2002 99:8707–8712. Epub 2002 June 18]Google Scholar
  68. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860–921PubMedGoogle Scholar
  69. Lansac J, Thepot F, Mayuax MJ (1997) Pregnancy outcome after artificial insemination or IVF with frozen semen donor: a collaborative study of the French CECOS Federation on 21,597 pregnancies. Eur J Obstet Gynecol Reprod Biol 74: 223–228PubMedGoogle Scholar
  70. Li C, Gronberg H, Matsuyama H, Weber G, Nordenskjold M, Naito K, Bergh A Bergerheim U, Damber JE, Larsson C, Ekman P (2003) Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene. Int J Mol Med 11:529–533PubMedGoogle Scholar
  71. Lillford R, Jones AM, Bishop DT, Thronton J, Mueller R (1994) Case control study of whether subfertility in men is familial. Br Med J 309:507–573Google Scholar
  72. Lin YM, Huang WJ, Lin JS, Kuo PL (2004) Progressive depletion of germ cells in a man with nonmosaic Klinefelter’s syndrome: optimal time for sperm recovery. Urology 63: 380–381PubMedGoogle Scholar
  73. Linden JV, Centola G (1997) New American Association of Tissue Banks standards for semen banking. Fertil Steril 68: 597–600PubMedGoogle Scholar
  74. Luetjens CM, Xu EY, Rejo Pera RA, Kamischke A, Nieschlag E, Gromoll J (2004) Association of meiotic arrest with lack of BOULE protein expression in infertile men. J Clin Endocrinol Metab 89:1926–1933PubMedGoogle Scholar
  75. Ma K, Sharkey A, Kirsch S, Vogt P, Keil R, Hargreave TB et al (1992) Towards the molecular localisation of the AZF locus: mapping of microdeletions in azoospermic men within 14 subintervals of interval 6 of the human Y chromosome. Hum Mol Genet 1:29–33PubMedGoogle Scholar
  76. Ma K, Inglis JD, Sharkey A, Bickmore WA, Hill RE, Prosser EJ et al (1993) A Y chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis. Cell 75:1–20Google Scholar
  77. Maines JZ, Wasserman SA (1999) Post-transcriptional regulation of the meiotic Cdc25 protein Twine by the Dazl orthologue Boule. Nat Cell Biol 1:171–174PubMedGoogle Scholar
  78. Mallidis C, Loveland K, Najmabadi H, McLaughlin R, Baker G, Bhasin S, de Kretser DM (1996) The incidence of the deleted in azoospermia gene in infertile men. In: Human Reproduction, Vol 11, Abstract book, 1 June 1996, 12th Annual Meeting, Maastricht, 30 June to 3 July 3 1996, European Society of Human Reproduction and Embryology, ISSN 0268-1161 Coden HUREEE, Oxford University PressGoogle Scholar
  79. Martin RH (1996) The risk of chromosomal abnormalities following ICSI. Hum Reprod 11:924–925PubMedGoogle Scholar
  80. Martin RH, McInnes B, Rademaker AW (1999) Analysis of aneuploidy for chromosomes 13, 21, X and Y by multicolour fluorescence in situ hybridisation (FISH) in a 47,XYY male. Zygote 7:131–134PubMedGoogle Scholar
  81. Martin RH, Rademaker AW, Greene C, Ko E, Hoang T, Barclay L, Chernos J (2003) A comparison of the frequency of sperm chromosome abnormalities in men with mild, moderate, and severe oligozoospermia. Biol Reprod 69:535–539PubMedGoogle Scholar
  82. Martini E, Geraedts JPM, Liebaers I, Land JA, Capitanio GL, Ramaekers FCS, Hopman AHN (1996) Constitution of semen samples from XYY and XXY males as analysed by in-situ hybridization. Hum Reprod 11:1638–1643PubMedGoogle Scholar
  83. Mercier B, Verlingue C, Lissens W, Silber SJ, Noveli G, Bonduelle M et al (1995) Is congenital bilateral absence of vas deferens primary form of cystic fibrosis? Analysis of the CFTR gene in 67 patients. Am J Hum Genet 56:272–277PubMedGoogle Scholar
  84. Moloney DM, Slaney SF, Oldridge M, Wall SA, Sahlin P, Stenman G, Wilkie AO (1996) Exclusive paternal origin of new mutations in Apert syndrome. Nature Genet 13:48–53PubMedGoogle Scholar
  85. Moog U, Coonen E, Dumoulin JCM, Engelen JJM (1996) Karyotypes of men involved in ICSI programmes: the Maastricht experience, April 1994 to date [abstract]. In: Human Reproduction, Vol 11, Abstract book, 1 June 1996, 12th Annual Meeting, Maastricht, 30 June to 3 July 1996. European Society of Human Reproduction and Embryology, ISSN 0268-1161 Coden HUREEE, Oxford University PressGoogle Scholar
  86. Moutou C, Gardes N, Viville S (2004) Duplex, triplex and quadruplex PCR for the preimplantation genetic diagnosis (PGD) of cystic fibrosis (CF), an exhaustive approach. Prenat Diagn 24:562–569PubMedGoogle Scholar
  87. Mulhall JP, Reijo R, Alagappan R, Brown L, Page D, Carson R, Oates RD (1997) Azoospermic men with deletion of the DAZ gene cluster are capable of completing spermatogenesis: fertilization, normal embryonic development and pregnancy occur when retrieved testicular spermatozoa are used for intracytoplasmic sperm injection. Hum Reprod 12:503–508PubMedGoogle Scholar
  88. Najmabadi H, Huang V, Yen P, Subbarao MN, Bhasin D, Banaag L et al (1996) Substantial prevalence of microdeletions of the Y chromosome in infertile men with idiopathic azoospermia and oligozoospermia detected using a sequence-tagged site-based mapping strategy. J Clin Endocrinol Metab 81: 1347–1352PubMedGoogle Scholar
  89. Nap AW, Van Golde RJ, Tuerlings JH, De Sutter P, Pieters MH, Giltay JC, Kastrop PM, Braat DD, Kremer JA (1999) Reproductive decisions of men with microdeletions of the Y chromosome: the role of genetic counselling. Hum Reprod 14: 2166–2169PubMedGoogle Scholar
  90. Nelson KA, Witte JS (2002) Androgen receptor CAG repeats and prostate cancer. Am J Epidemiol 155:883–890PubMedGoogle Scholar
  91. Nudell D, Castillo M, Turek PJ, Pera RR (2000) Increased frequency of mutations in DNA from infertile men with meiotic arrest. Hum Reprod 15:1289–1294PubMedGoogle Scholar
  92. Oates RD, Amos JA (1994) The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. J Androl 15:1–8PubMedGoogle Scholar
  93. Okada H, Fujioka H, Tatsumi N, Kanzaki M, Okuda Y, Fujisawa M et al (1999) Klinefelter’s syndrome in the male infertility clinic. Hum Reprod 14:946–952PubMedGoogle Scholar
  94. Okada H, Shirakawa T, Ishikawa T, Goda K, Fujisawa M, Kamidono S (2004) Serum testosterone levels in patients with nonmosaic Klinefelter syndrome after testicular sperm extraction for intracytoplasmic sperm injection. Fertil Steril 82:237–238PubMedGoogle Scholar
  95. Ostermeier GC, Miller D, Huntriss JD, Diamond MP, Krawetz SA (2004) Reproductive biology: delivery spermatozoan RNA to the oocyte. Nature 429:154PubMedGoogle Scholar
  96. Page DC, Silber S, Brown LG (1999) Men with infertility caused by AZFc deletion can produce sons by intracytoplasmic sperm injection, but are likely to transmit the deletion and infertility. Hum Reprod. 14:1722–1726PubMedGoogle Scholar
  97. Pantazidis AC, Galanopoulos VK, Zouros E (1993) An autosomal factor from Drosophila mojavensis restores normal spermatogenesis in Drosophila males carrying the D. arizo nae Y chromosome. Genetics 134:309–318PubMedGoogle Scholar
  98. Persson JW (1999) A hypothesis on the origin of germ cell mutation and evolutionary role of extraembryonic mutation. Hum Reprod 14:1840–1841PubMedGoogle Scholar
  99. Persson JW, Peter GB, Saunders DM (1996) Is ICSI associated with risks of genetic disease? Implications for counselling, practice and research. Hum Reprod 11:921–924PubMedGoogle Scholar
  100. Peschka B, Leygraaf J, van der Ven K, Montag M, Schartmann B, Schubert R et al (1999) Type and frequency of chromosome aberrations in 781 couple undergoing intracytoplasmic sperm injection. Hum Reprod 14:2257–2263PubMedGoogle Scholar
  101. Pinborg A, Loft A, Rasmussen S, Schmidt L, Langhoff-Roos J, Greisen G Andersen AN (2004) Neonatal outcome in a Danish national cohort of 3438 IVF/ICSI and 10,362 non-IVF/ICSI twins born between 1995 and 2000. Hum Reprod 19:435–441PubMedGoogle Scholar
  102. Pryor JL, Kent First M, Muallem A et al (1997) Microdeletions in the Y chromosome of infertile men. N Engl J Med 336:534–539PubMedGoogle Scholar
  103. Qureshi SJ, Ross AR, Ma K, Cooke HJ, McIntyre MA, Hargreave TB (1996) Polymerase chain reaction screening for Y chromosome microdeletions: a first step towards the diagnosis of genetically determined spermatogenetic failure in men. Mol Hum Reprod 2:775–779PubMedGoogle Scholar
  104. Ratcliffe S (1999) Long term outcome in children of sex chromosome abnormalities. Arch Dis Child 80:192–195PubMedGoogle Scholar
  105. Reijo R, Lee TY, Salo P, Alagappan R, Brown LG, Rosenberg M, Rozen S et al (1995) Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNAbinding protein gene. Nature Genet 10:383–393PubMedGoogle Scholar
  106. Reijo R, Alagappan PK, Patrizio P et al (1996) Severe oligozoospermia resulting from deletions of azoospermia factor gene on Y chromosome. Lancet 347:1290–1293PubMedGoogle Scholar
  107. Repping S, Skaletsky H, Lange J, Silber S, Van Der Veen F, Oates RD, Page DC, Rozen S (2002) Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet 71:906–922PubMedGoogle Scholar
  108. Roest HP, Van Klaveran J, de Wit J, van Gurp CG, Koken MHM, Vermy M (1996) Inactivation of the HR6B ubiquitin conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification. Cell 86:799–810PubMedGoogle Scholar
  109. Rovio AT, Marchington DR, Donat S, Schuppe HC, Abel J, Fritsche E, Elliott DJ, Laippala P, Ahola AL, McNay D, Harrison RF, Hughes B, Barrett T, Bailey DM, Mehmet D, Jequier AM, Hargreave TB, Kao SH, Cummins JM, Barton DE, Cooke HJ, Wei YH, Wichmann L, Poulton J, Jacobs HT (2001) Mutations at the mitochondrial DNA polymerase (POLG) locus associated with male infertility. Nat Genet 29:261–262PubMedGoogle Scholar
  110. Rozen S, Skaletsky H, Marszalek JD, Minx PJ, Cordum HS, Waterston RH, Wilson RK, Page DC (2003) Abundant gene conversion between arms of palindromes in human and ape Y chromosomes. Nature 423:873–876PubMedGoogle Scholar
  111. Saunders PT, Turner JM, Ruggiu M, Taggart M, Burgoyne PS, Elliott D, Cooke HJ (2003) Absence of mDazl produces a final block on germ cell development at meiosis. Reproduction 126:589–597PubMedGoogle Scholar
  112. Sauten RJ, Paulsen CA (1973) Hypogonadotrophic eunuchoidism. I. Clinical study of the mode of inheritance. J Clin Endocrinol Metab 36:47–54Google Scholar
  113. Saxena R, Brown LG, Hawkins T, Alagappan RK, Skaletsky H, Reeve MP, Reijo R, Rozen S, Dinulos MB, Disteche CM, Page DC (1996) The DAZ gene cluster on the human Y chromosome arose from an autosomal gene that was transposed, repeatedly amplified and pruned. Nat Genet 14:292–299PubMedGoogle Scholar
  114. Schempp W, Binkele A, Arnemann J, Glaser B, Ma K, Taylor K et al (1995) Comparative mapping of YRRM and TSPY related cosmids in man and homonoid apes. Chromosome Res 3:227–237PubMedGoogle Scholar
  115. Short RV (1997) The testis, the witness of the mating system, the site of mutation and the engine of desire. Acta Paediatr (Suppl) 422:3–7Google Scholar
  116. Sibley CG, Comstock JA, Ahlquist JE (1990) DNA hybridization evidence of hominoid phylogeny: a re-analysis of the data. J Mol Evol 30:202–236PubMedGoogle Scholar
  117. Silber SJ, Alagappan R, Brown LG, Page DC (1998) Y chromosome deletions in azoospermic and severely oligozoospermic men undergoing intracytoplasmic sperm injection after testicular sperm extraction. Hum Reprod 13:3332–3337PubMedGoogle Scholar
  118. Simmerly C, Wu GJ, Zoran S et al (1995) The paternal inheritance of the centrosome, the cells microtubular organizing center in humans and the implications for infertility. Nature Med 1:47–52Google Scholar
  119. Simoni M, Gromoll J, Dwoniczak B et al (1997) Screening for deletions of the Y chromosome involving the DAZ (deleted in Azoospermia) gene in azoospermia and severe oligozoospermia. Fertil Steril 67:542–547PubMedGoogle Scholar
  120. Simoni M, Kamischke A, Nieschlag E (1998) Current status of the molecular diagnosis of Y-chromosomal microdeletions in the work-up of male infertility. Initiative for international quality control. Hum Reprod 13:1764–1768PubMedGoogle Scholar
  121. Simoni M, Gromoll J, Hoppner W, Kamischke A, Krafft T, Stahle D, Nieschlag E (1999) Mutational analysis of the folliclestimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 84:751–755PubMedGoogle Scholar
  122. Simpson JL, de la Cruz F, Swerdloff RS, Samango-Sprouse C, Skakkebaek NE, Graham JM, Hassold T, Aylstock M, MeyerBahlburg HF, Willard HF, Hall JG, Salameh W, Boone K, Staessen C, Geschwind D, Giedd J, Dobs AS, Rogol A, Brinton B, Paulsen CA (2003) Klinefelter syndrome: expanding the phenotype and identifying new research directions. Genet Med 5:460–468PubMedGoogle Scholar
  123. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, Brown LG, Repping S, Pyntikova T, Ali J, Bieri T, Chinwalla A, Delehaunty A, Delehaunty K, Du H, Fewell G, Fulton L, Fulton R, Graves T, Hou SF, Latrielle P, Leonard S, Mardis E, Maupin R, McPherson J, Miner T, Nash W, Nguyen C, Ozersky P, Pepin K, Rock S, Rohlfing T, Scott K, Schultz B, Strong C, Tin-Wollam A, Yang SP, Waterston RH, Wilson RK, Rozen S, Page DC (2003) Related articles, links [Abstract]. The malespecific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423:825–837PubMedGoogle Scholar
  124. Soulard M, Della Valle V, Siomi MC, Pinol-Roma S, Codogno P, Bauvy C et al (1993) hnRNP G: sequence and characterization of a glycosylated RNA-binding protein. Nucleic Acids Res 21:4210–4217PubMedGoogle Scholar
  125. Staessen C, Tournaye H, Van Assche E, Michiels A, Van Landuyt L, Devroey P, Liebaers I, Van Steirteghem A (2003) PGD in 47,XXY Klinefelter’s syndrome patients. Hum Reprod Update 9:319–330PubMedGoogle Scholar
  126. Stuppia L, Mastroprimiano G, Calabrese G et al (1996) Microdeletions in interval 6 of the Y chromosome detected by STS-PCR in 6 of 33 patients with idiopathic oligo-or azoospermia. Cytogenet Cell Genet 72:155–158PubMedGoogle Scholar
  127. Stuppia L, Gatta V, Mastroprimiano G (1997) Clustering of Y chromosome deletions in subinterval E of interval 6 supports the existence of an oligozoospermia critical region outside the DAZ gene. J Med Genet 34:881–883PubMedGoogle Scholar
  128. Sun C, Skaletsky H, Birren B, Devon K, Tang Z, Silber S, Oates R, Page DC (1999) An azoospermic man with a de novo point mutation in the Y-chromosomal gene USP9Y. Nat Genet 23:429–432PubMedGoogle Scholar
  129. Tesarik J (2004) Overcoming maturation arrest by in vitro spermatogenesis: search for the optimal culture system. Fertil Steril 81:1417–1419PubMedGoogle Scholar
  130. Tessari A, Salata E, Ferlin A, Bartoloni L, Slongo ML, Foresta C (2004) Characterisation of HSFY, a novel AZFb gene on the Y chromosome with a possible role in spermatogenesis. Mol Hum Reprod 10:253–258PubMedGoogle Scholar
  131. Tiepolo L, Zuffardi O (1976) Location of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm. Hum Genet 34:119–124PubMedGoogle Scholar
  132. Tincello DG, Saunders PTK, Hargreave TB (1997) Preliminary investigations on androgen receptor gene mutations in infertile men. Mol Hum Reprod 3:941–943PubMedGoogle Scholar
  133. Tolarova MM, Harris JA, Ordway DE, Vargervik K (1997) Birth prevalence, mutation rate, sex ratio, parent’s age and ethnicity in Apert syndrome. Am J Med Genet 72:394–398PubMedGoogle Scholar
  134. Tournaye H, Devroey P, Liu J, Nagy Z, Lissens W, Van Steirteghem A (1994) Microsurgical epididymal sperm aspiration and intracytoplasmic sperm injection: a new effective approach to infertility as a result of congenital bilateral absence of the vas deferens. Fertil Steril 61:1045–1051PubMedGoogle Scholar
  135. Tournaye H, Staessen C, Liebaers I, Van Assche EV, Devroey P Bonduelle M Steirteghem AV (1996) Testicular sperm recovery in nine 47 XXY Klinefelter patients. Hum Reprod 11: 1644–1649PubMedGoogle Scholar
  136. Ulug U, Bener F, Akman MA, Bahceci M (2003) Partners of men with Klinefelter syndrome can benefit from assisted reproductive technologies. Fertil Steril 80:903–906PubMedGoogle Scholar
  137. Van Assche E, Bonduelle M, Tournaye H, Joris H, Verheyen G, Devroey P et al (1996) Cytogenetics of infertile men. Hum Reprod 11 [Suppl 4]:1–24PubMedGoogle Scholar
  138. van der Ven K, Messer L, van der Ven H, Jeyendran RS, Ober C (1996) Cystic fibrosis mutation screening in healthy men with reduced sperm quality. Hum Reprod 11:513–517PubMedGoogle Scholar
  139. Van Kooij RJ, de Boer P, De Vreedenb-Elbertse JM, Ganga NA, Singh N, Te Velde (2004) The neutral comet assay detects double strand DNA damage in selected and unselected human spermatozoa of normospermic donors. Int J Androl 27:140–146PubMedGoogle Scholar
  140. Venables JP, Cooke HJ (2000) Lessons from knockout and transgenic mice for infertility in men. J Endocrinol Invest 23:584–591PubMedGoogle Scholar
  141. Vernaeve V, Staessen C, Verheyen G, Van Steirteghem A, Devroey P, Tournaye H (2004) Can biological or clinical parameters predict testicular sperm recovery in 47,XXY Klinefelter’s syndrome patients? Hum Reprod 19:1135–1139PubMedGoogle Scholar
  142. Vogt PH (1999) Risk of neurodegenerative diseases in children by intracytoplasmic sperm injection? Lancet 354:611–612PubMedGoogle Scholar
  143. Vogt P, Chandley AC, Hargreave TB, Keil R, Ma K, Sharkey A (1992) Microdeletions in interval 6 of the Y chromosome of males with idiopathic sterility point to disruption of AZF, a human spermatogenesis gene. Hum Genet 89:491–496PubMedGoogle Scholar
  144. Vogt P, Edelmann A, Kirsch S (1996) Human Y chromosome azoospermic factors AZF mapped to different regions in Ya11. Hum Mol Genet 5:933–943PubMedGoogle Scholar
  145. Wang C, Baker HWG, Burger HG et al (1975) Hormonal studies in men with Klinefelters syndrome. Clin Endocrinol 4: 399–414Google Scholar
  146. Wang PJ, McCarrey JR, Yang F, Page DC (2001) An abundance of Xlinked genes expressed in spermatogonia. Nat Genet 27:422–426PubMedGoogle Scholar
  147. Westerveld GH, Gianotten J, Leschot NJ, van der Veen F, Repping S, Lombardi MP (2004) Heterogeneous nuclear ribonucleoprotein G-T (HNRNP G-T) mutations in men with impaired spermatogenesis. Mol Hum Reprod 10:265–269PubMedGoogle Scholar
  148. Wu CC, Hsieh-Li HM, Lin YM, Chiang HS (2004) Cystic fibrosis transmembrane conductance regulator gene screening and clinical correlation in Taiwanese males with congenital bilateral absence of the vas deferens. Hum Reprod 19:250–253PubMedGoogle Scholar
  149. Xu EY, Moore FL, Pera RA (2001) A gene family required for human germ cell development evolved from an ancient meiotic gene conserved in metazoans. Proc Natl Acad Sci USA 98:7414–7419PubMedGoogle Scholar
  150. Zhang LU (2004) Investigation of the frequency of chromosomal aneuploidy using triple fluorescence in situ hybridization in 12 Chinese infertile men. Chinese Med J 117: 503–506Google Scholar

Bibliografia

  1. American Society of Clinical Oncology (2003) American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21:2397–2406Google Scholar
  2. Bateman AC, Howell WM (1999) Human leukocyte antigens and cancer: is it in our genes? J Pathol 188:231–236PubMedGoogle Scholar
  3. Bennett RL, Steinhaus KA, Uhrich SB et al (1995) Recommendations for standardized human pedigree nomenclature. J Genet Couns 4:267–279Google Scholar
  4. Birkeland SA, Storm HH, Lamm LU et al (1995) Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 60:183–189PubMedGoogle Scholar
  5. Bratt O, Dumber JE, Emanuelsson M, Gronberg H (2002) Hereditary prostate cancer:clinical characteristics and survival. J Urol 167:2423–2426PubMedGoogle Scholar
  6. Cannon L, Bishop DT, Skolnick M et al (1982) Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1:47–69Google Scholar
  7. Carter BS, Beaty TH, Steinberg GD et al (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89:3367–3371PubMedGoogle Scholar
  8. Damber JE (2001) Familial aggregation of prostate cancer management while waiting for the identification of hereditary prostate cancer genes. Eur Urol 39 [Suppl. 4]:19–21PubMedGoogle Scholar
  9. Dieckman KP, Pichlmeier U (1997) The prevalence of familial testicular cancer: an analysis of two patient populations and a review of the literature. Cancer 80:1954–1960Google Scholar
  10. Dong C, Lonnstedt I, K. Hemminki (2001) Familial testicular cancer and second primary cancers in testicular cancer patients by histological type. Eur J Cancer 37:1878–1885PubMedGoogle Scholar
  11. Forman D, Oliver RT, Brett AR et al (1992) Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer 65:255–262PubMedGoogle Scholar
  12. Ghadirian P, Howe GR, Hislop TG et al (1997) Family history of prostate cancer: a multi-center case-control study in Canada. Int J Cancer 70:679–681PubMedGoogle Scholar
  13. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1608PubMedGoogle Scholar
  14. Goss PE, Bulbul MA (1990) Familial testicular cancer in five members of a cancer-prone kindred. Cancer 66:2044–2046PubMedGoogle Scholar
  15. Gronberg H, Damber L, Damber JE (1996) Familial prostate cancer in Sweden. A nationwide register cohort study. Cancer 77:138–143PubMedGoogle Scholar
  16. Gronberg H, Damber L, Tavelin B, Damber JE (1998) No difference in survival between sporadic, familial and hereditary prostate cancer. Br J Urol 82:564–567PubMedGoogle Scholar
  17. Gronberg H, Bergh A, Damber JE, Emanuelsson M (2000) Cancer risk in families with hereditary prostate carcinoma. Cancer 89:1315–1321PubMedGoogle Scholar
  18. Heimdal K, Olsson H, Trestly S et al (1996) Familial testicular cancer in Norway and Southern Sweden. Br J Cancer 73:964–969PubMedGoogle Scholar
  19. Lichtenstein P, Holm NV, Verkasalo PK et al (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85PubMedGoogle Scholar
  20. Looijenga LH, de Leeuw H, van Oorschot M et al (2003) Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumours. Cancer Res 63:7674–7678PubMedGoogle Scholar
  21. Lutke Holzik MF, Sijmons RH, Sleijfer DT et al (2003) Syndromic aspects of testicular carcinoma. Cancer 97:984–992PubMedGoogle Scholar
  22. Lutke Holzik MF, Rapley EA, Hoekstra HJ et al (2004) Genetic predisposition to testicular germ-cell tumours. Lancet Oncol 5:363–371PubMedGoogle Scholar
  23. Matikaine MP, Pukkala E, Schleutker J et al (2001) Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland. Cancer Causes Control 12:223–230PubMedGoogle Scholar
  24. Nieder AM, Taneja SS, Zeegers MPA, Ostrer H (2003) Genetic counselling for prostate cancer risk. Clin Genet 63:169–176PubMedGoogle Scholar
  25. Osterlind A, Berthelsen JG, Abildgaard N et al (1991) Risk of bilateral testicular germ cell cancer in Denmark 1960–1984. J Natl Cancer Inst 83:1391–1395PubMedGoogle Scholar
  26. Petersen GM (2000) Genetic testing. Hematol Oncol Clin North Am 14:939–952PubMedGoogle Scholar
  27. Raney AM, Jhaveri KK (1981) Familial carcinoma of penis. NY State J Med 81:1786–1787Google Scholar
  28. Sonneveld DJ, Sleijfer DT, Schraffordt Koops H et al (1999) Familial testicular cancer in a single-centre population. Eur J Cancer 35:1368–1373PubMedGoogle Scholar
  29. Spano JP, Atlan D, Breau JL, Farge D (2002) AIDS and nonAIDS-related malignancies: a new vexing challenge in HIVpositive patients: part II, cervical and anal squamous epithelial lesions, lung cancer, testicular germ cell cancers, and skin cancers. Eur J Intern Med 13:227–232PubMedGoogle Scholar
  30. Steinberg GD, Carter BS, Beaty TH et al (1990) Family history and the risk of prostate cancer. Prostate 17:337–347PubMedGoogle Scholar
  31. Swerdlow AJ, Higgins CD, Pike MC (1997) Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ 314: 1507–1511PubMedGoogle Scholar
  32. UK Testicular Cancer Study Group (1994) Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. BMJ 308:1393–1399Google Scholar
  33. Valeri A, Azzouzi R, Drelon E et al (2000) Early-onset hereditary prostate cancer is not associated with specific clinical and biological features. Prostate 45:66–71PubMedGoogle Scholar
  34. Wanderas EH, Fossa SD, Tretli S (1997) Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients. Eur J Cancer 33:244–252PubMedGoogle Scholar
  35. Zeegers MP, Jellema A, Ostrer H (2003) Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer 97:1894–1903PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2010

Authors and Affiliations

  • Timothy B. Hargreave
    • 1
  • Frank Comhaire
    • 2
  • Ahmed Mahmoud
    • 2
  • Hans Gerd Schiefer
    • 3
  • Alexander von Graevenitz
    • 4
  • Dietrich Klingmüller
    • 5
  • N. Bliesener
    • 5
  • Gerhard Haidl
    • 6
  • Marc E. Bracke
    • 7
    • 8
  • Els L. F. Nijs
    • 9
  • Raymond H. Oyen
    • 10
  • Yigal Gat
    • 11
  • Michael Gornish
    • 12
  • Martin Bergmann
    • 13
  • David J. Elliott
    • 14
  • Oleg Tatarov
    • 15
  • David Kirk
    • 15
  1. 1.Department of OncologyEdinburgh University, Human Genetics Building, Western General HospitalEdinburghUK
  2. 2.Centre for Medical and Urological Andrology and Reproductive EndocrinologyUniversity Hospital Ghent 6K12IEGhentBelgium
  3. 3.Department of Medical Microbiology, Justus LiebigUniversity Giessen, Schubertstr. 1GiessenGermany
  4. 4.Department of Medical MicrobiologyUniversity of ZürichZürichSwitzerland
  5. 5.Institute for Clinical Biochemistry, EndocrinologyUniversity of BonnBonnGermany
  6. 6.Department of Dermatology/Andrology UnitUniversity of BonnBonnGermany
  7. 7.Laboratory of Experimental Cancerology, Department of Radiotherapy and Nuclear MedicineUniversity Hospital, De Pintelaan 185GhentBelgium
  8. 8.Laboratory NuytinckEvergemBelgium
  9. 9.Department of Radiology, University Hospitals GasthuisbergKatholieke Universiteit LeuvenLeuvenBelgium
  10. 10.Department of RadiologyUniversity Hospitals Gasthuisberg, Katholieke Universiteit LeuvenLeuvenBelgium
  11. 11.Andrology Unit, Department of Obstetrics and Gynecology, Rabin Medical Center, Beilinson Campus, Petah Tiqva and Sackler Faculty of MedicineTel Aviv UniversityTel AvivIsrael
  12. 12.Department of Radiology and the Interventional and Vascular Unit, Rabin Medical Center, Beilinson Campus, Petah Tiqva and Sackler Faculty of MedicineTel Aviv UniversityIsrael
  13. 13.Institute of Veterinary Anatomy, Histology and EmbryologyJustus Liebig UniversityGiessenGermany
  14. 14.Institute of Human Genetics, International Centre for LifeUniversity of Newcastle-upon-TyneNewcastleUK
  15. 15.Urology DepartmentGartnavel General HospitalGlasgowUK

Personalised recommendations